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CHAPI'ER I

INTRODUCTION
vJorld War I caused a great increase in the demand for acetone
which was needed in the manufacture of cordite and airplane wing dope.
The available supplies of acetone were inadequate and researchers began
to investigate fermentation processes for the conversion of carbohydrate
to acetone.

Northrup et. al., (1919) found, that during the fermentation

of potatoes, high levels of acetone and ethyl alcohol were produced.
From the fermenting potatoes, the workers isolated a microorganism
responsible for the production of acetone and ethyl alcohol.

Microscopic

morphology showed the organism to be gram negative and rod-shaped.
Northrup et. al., (1919) named the microorganism Bacillus acetoethylicum
on the basis of the cell morphology and end products produced during
the fermentation of potatoes.

Reilly et. al., (1920) isolated a micro-

organism from the fermentation of corn mash.

The workers found that

during the fermentation of corn mash, there are high levels of acetone,
butyl alcohol and ethyl alcohol produced.

As the pH of the culture medium

began to drop, there were further increases in the production of acetone.
If the acidification of the culture medium was prevented, the production
of acetone was curtailed.

On the other hand, the addition of acetic

acid to the culture medium resulted in increased production of acetone by
the microorganism.

Johnson et. al., (1933) studied the intermediate

compounds in the acetone-butyl alcohol fermentation of corn mash.

These

workers discovered that the acetone produced in the culture medium and

2

from centrifuged washed cells of Clostridium acetobutylicum arose from
the decarboxylation of acetoacetic acid.

The production of acetic acid

in the culture medium was found to be responsible for the decreasing pH.
1
Wood et. al. (1945) studied the effect of adding (1- 3c-) acetate to the
culture medium, and found that the labeled carbon was incorporated
exclusively into acetone.

To account for this, a mechanism Has proposed

in which two moles of acetate condense to form one mole of acetoacetate:
the acetoacetate, in turn, is decarboxylated to form one mole each of
acetone and carbon dioxide.
Early work on cell free extracts of Clostridium acetobutylicum
was carried out by Davies ( 1943).

I)artial purification of acetoacetate

decarboxylase (E. C. 4.1.1.4 acetoacetate carboxylase) was
extraction of acetone powder of washed cells of
acetobutylicum.

attai~ed

by

Clostridiu~

The enzyme has an optimum pH of

5.0 and a Km of 8mM.

'lhe enzyme is heat stable and is inhibited by heavy metal jons such as
mercuric, silver, cupric and ferric.

Davies also demonstrated

enzyme associated with Clostridium acetobutylicum

t~~t

the

is very specific for

acetoacetate and it will not decarboxylate either alpha or other beta
keto acids.

Since its initial partial purification by Davies (191~3), the

enzyme has been extensively purified (Hamilton and Westheimer 1959a) and
subsequently crystallized (Zerner et. al., 1966).

These procedures were

described as follows:
The spores of ~ridium acetobutylicum are harvested
from sterile sand and grown in test tubes containing a
growth medium of L (+) arabinose, trypticase, yeast
extract, 1-asparagine, and ascorbic acid. The salt
composition of the medium comprises magnesium sulfate
heptahydrate, manganous sulfate monohydrate, ferrous
sulfate heptahydrate and sodium chloride. Growth is

3
evident by gas evolution after approximately 24 hours.
After 4-7 days, the bacteria are used to inoculate 20
liter carboys of the growth medium. After 3 days, the
cells are harvested by centrifugation and used to prepare an acetone powder. The packed cells are homogenized with cold acetone in a chilled Waring blender.
The dehydrated cells are collected on a Buchner funnel
and washed with cold acetone. The filter cake is dried
in vacuo and ground with a mortar and pestle. Each
100 g of acetone powder is extracted for 2 hours at
37'C on a rotary shaker with 1500 ml of 50 mM phosphate
buffer, pH 5.9. The most important step in the
purification proeedure is the precipitation of the
active material from the clear extract by acidification
to pH 3.8-3.9 with 2 M acetic acid. The protein is
collected by centrifugation for 2 hours at 3900 rpm at
4'C, The assay of this material reveals a 20-67 fold
increase in the specific activity of the enzyme. The
protein is collected, resuspended in 100 ml of 50 ~
phosphate buffer, pH 5.9 and mixed to redissolve the
material, The suspension is clarified by centrifugation at 10,000 rpm. The enzyme is precipitated out
of the clarified solution at 60% saturation with
solid ammonium sulfate at room temperature. The
enzyme is collected by centrifugation, dissolved in
10-15 ml of 50 ~ phosphate buffer and desalted by
dialysis against phosphate buffer, pH 5.9. The
solution is heat-activated at 55'C for 1 hour and
purified by passing the protein through a DEAE
cellulose column equilibrated with the phosphate
buffer. The buffer is passed through the column
until no more material which absorbs at 280 nm is
observed. The column is then subjected to an ammonium
sulfate salt gradient from 0-0.1 M. The enzyme is
eluted in a well defined, sharp peak. Fractions which
exhibit a 280 nmc 260 nm ratio of 1.9 or greater are
pooled and brought to 75% saturation with ammonium
sulfate. The precipitated· protein is collected by
centrifugation at 10,000 rpm. Once again the material
is dissolved in 5-10 ml of 50 ~ phosphate buffer, pH 5.9
and crystallized at room temperature by the successive
addition of small amounts of solid ammonium sulfate
on a stirring rod. The growth of thin hexagonal plates
are observed after about 12 hours.
An interesting property of the bacterial enzyme is that of latent
enzymatic activity.

Latent activity is exposed after the enzyme is

heated at 55'C for 1 hour.

The activation by heat causes a two-fold

4
increase in the enzymatic activity.

The activation is first order and

effectively irreversible (Neece and Fridovich, 1967).

They reported

that the rate of activation is not affected by dilution of the enzyme
solution, dialysis or extensive purification.

The latent decarboxylase

will co-sediment with the expressed activity in a sucrose density gradient.

tTeece and Fridovich (1967) postulated that the latent material

is converted to active enzyme by a conformational change within the
latent enzyme.

Once the latent enzyme sites are activated, they cannot

be distinguished from the original active enzyme with respect to inhibition by monovalent anions, to substrates and to known competitive inhibitors of the active enzyme.

Attempts to activate latent siteG by the

use of denaturants such as urea and ethanol, or with the

of the

additio~

proteolytic enzymes trypsin, o<-chymotryspin and pronase were unsuccessful.

-r-;othing is known about chemical nature of the latent sHe or

the reason why the native enzyme contains latent enzyme sites.
The molecular weight of the bacterial enzyme is J40,000 + 10,000
as determined by equilibrium sedimentation (Tagaki and Hestheimer (1968a).
After exposure to pH 2.5, 4.0

~urea

the enzyme dissociates into its subunits.
29,000

~

~guanidine

or 6.0

hydrochloride,

Each subunit weighs

1,000 and it appears that the native enzyme is a dodecamer.

the native enzyme is subjected to a pH of 8 and 4.0
will dissociate into dimers weighing 60,000.

~urea,

If

the enzyme

Once the urea has been re-

moved, the dimers will reassociate to form the native dodecamer.

How-

ever, if the dodecamer is dissociated into the monomers, these will not
reassociate to form the dodecamer or any intermediate molecular species.

5
The amino acid content of the subunit has been determined by
Lederer et al., (1966).

Methionine is the only N-terminal amino acid

present and lysine appears at the C-terminal.

The amino acid composi-

tion shows 20 lysine residues, 12-13 arginine residues and 9 histidine
residues.

The positive charges are countered by 29 aspartic acid resi-

dues and 20 glutamic acid residues; 17 of the glutamic acid residues are
bound as amides.

At pH 5.0 it would be expected that the molecule would

possess a strong positive charge yet its isoelectric point is 4.9
(Lederer et al., 1966).
The bacterial enzyme is stable at 25"C in the pH range of 4-9
(Lederer et. al., 1966).

The enzyme is inactivated by denaturants such

as urea, guanidine hydrochloride and sodium dodecyl sulfate (Tagaki,
1968).

The enzyme is resistant to heat; heating at 70"C in a 50 ~

phosphate buffer, pH 5.9, results in no perceptible loss of activity
(Autor and Fridovich, 1970b).

When the enzyme is subjected to tempera-

tures above 70·c, there is an irreversible loss of activity.

The loss of

activity appears to be biphasic; there is a rapidly inactivated component (within 10 minutes) and a slowly inactivated component (within 60
minutes).

Autor and Fridovich (1970b) postulated that during heat in-

activation, the native enzyme is converted either to an inactive enzyme
or a modified enzyme which contains less activity than the native enzyme.
The modified enzyme is then converted at a very slow rate to the inactive species.

The presence of acetylacetone will prevent the thermal

inactivation of the enzyme up to a temperature of 85"C.

It is not known

how acetylacetone performs this action.
Hamilton and Westheimer (1959b) first proposed that the mechanism of
action for the bacterial enzyme occurred through a Schiff base inter-
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mediate formed between the beta carbonyl group of acetoacetate and a
specific amino group in the active site.

The proposed mechanism was

based upon the observation that there occurs an obligatory oxygen exchange between labeled oxygen in the carbonyl position and the solvent
water.

The oxygen exchange is a necessary step in the formation of a

Schiff base.

Schiff bases are extremely susceptible to reduction by so-

dium borohydride.

Fridovich and Westheimer (1962) used this information

to demonstrate that'sodium borohydride will inhibit the bacterial
matic activity.

en~

Sodium borohydride will reduce the ketimine interme-

diate which is formed between the enzyme and substrate.

The reduction

produces a complex which inactivates the enzyme by blocking the active
site and acting as a non-competitive inhibitor.

Fridovich and

~-Jestheimer

(1962) were able to trap the Schiff base intermediate and to detect it
radiochemically.

Acetoacetate labeled in the carbonyl positjon with

carbon-14 was reacted with the enzyme and sodium borohydride.

The

borohydride reduced an intermediate and formed a stable radioactivelylabeled enzyme complex.

Unreacted acetoacetate and labeled acetone pro-

duced by nonenzymatic decarboxylation of acetoacetate were removed by
dialysis and the radioactivity of the enzyme complex was counted by
liquid scintillation.

The borohydride reduction with labeled substrate

resulted in an 18-fold increase in the radioactivity incorporated into
the enzyme.

chlorj.c acid,

The labeled enzyme Has subjected to hydrolysis with hydro-

The hydrolysate was subjected to two dimensio:1al paper

chromatography and radioautography.

The radioautograph showed a sir.gle

spot responsible for the radioactivity.

Fridovich and 1!estheimer (1962)

had thus trapped the Schiff base intermediate with the sodium borohydride
reaction and given further evidence for its existen.ce.

These results

7
indicated that borohydride reduces a compound formed between the enzyme
and acetoacetate and that this reduction forms a bond stable to acid
hydrolysis.

The available evidence supported the concept that the

enzymatic decarboxylation of acetoacetate proceeds by way of a Schiff
base intermediate.
The amino acid sequence of the active site has been determined by
Laursen and Westheimer (1966).

The workers subjected the borohydride-

reduced radiochemically trapped enzyme to the proteolytic actions of
trJpsin and chymotrypsin.

The peptides were separated by column

chromatography and the radioactive peptide was sequenced.

The sequence

of the peptide was identified as followsc
- GLU - LEU - SER - ALA - TYR - PRO - LYS* - LYS - LEU
The lysine bearing the asterisk represents the site of the Schiff
base formation.

A single one lysine residue in the active site seems

to account for the catalytic activity of acetoacetate decarboxylase.
Currently, the proposed scheme for the mechanism of action of acetoacetate decarboxylation is as follows (Warren et. al., 1966):

0

k1
II
+ CH ccH COO
2
2
3
k;-:-1
H
I+ .
C0 +
H-N -E
2
H-r-E
-H+
k2
CH -C=CH
CH -C=CH
3
2
+H+ k33 ~ H+2

-

ENH

CH -C-CH -COO - + H20
3
2
+H+
-H+

"

jr

+

~~~-

I

H.;.ll+-E

II

-H

CH -C-CH

3

8

N-E

CH -C-CH -C-0
3® 2
N-E

+

II

CH -c-CH

3

3

+H+

®

k4

!

3

H 0
2

CH -ft-CH +ENH 2
3
3
0

ENH

2

= enzyme

In the first step of the mechanistic scheme, there is a nucleophilic attack by the episilon amino group of the reactive lysine on the
beta carbonyl group of acetoacetate.

The nucleophilic attack results in

the formation of a Schiff base with the obligatory oxygen exchange described by Hamilton and

Westheimer (1959b).

The Schiff base in the

first reaction is referred to as the enzyme-substrate complex.

The en-

zyme substrate complex is reduced to form a Schiff base salt or a
ketimine (labeled A in the Scheme).

The ketimine has a localized posi-

tive charge which pulls electrons from the carboxylate terminal by a
process known as induction.

The induced electrons stabilize the complex

and the first product carbon dioxide is released.

The resulting complex

then undergoes reduction to form a Schiff base salt of the enzyme-pro-

9
duct complex (labeled B in the Scheme).

Both Schiff base salts

(A and B) are susceptible to reduction by borohydride; however only the
ketimine B salt has been isolated.

Tagaki et al., (1968d) has suggested

that the conversion of ketimine A to B is very rapid and, therefore,
little or no reduction occurs at complex A.

The ketimine B is oxidized

to form the Schiff base of acetone and this complex subsequently undergoes hydrolysis to yield the final product acetone and releases the free
enzyme.
Acetopyruvate, a 'CGmpetitive inhibitor of the bacterial enzyme, will
protect the enzyme against reduction by borohydride (Tagaki, et. al.,
1968).

Acetopyruvate is a beta diketone and thus is an analogue of the

substrate acetoacetate.

Acetopyruvate has been shown to bind to the

active site of the enzyme; however, the acetopyruvate enzyme complex
will not go on to form a product or any other intermediate.

The

acetopyruvate enzyme complex will not support the borohydride reduction
because the complex formed between the analogue is electron-rich.
Borohydride will reduce carbon to nitrogen double bonds of Schiff bases
and Schiff base salts which are relatively electron-deficient.

The

enamine double bond formed between acetopyruvate and enzyme is electronrich, and therefore, not reducible by borohydride.
Below is an example of the electron-deficient complex formed between acetoacetate and the bacterial enzyme and the electron-rich bond
formed between acetopyruvate and the enzyme.

CH -C-CH
3 II
3
+
H-N -E
Electron-deficient Schiff base salt of acetone

10
CH

3

-C-~ = c-eo I 2
II
0
~

Electron-rich acetopyruvate enzyme complex
The formation of the acetopyruvate enzyme complex gives evidence
for the existence of ketimine A in the mechanistic scheme.

The aceto-

pyruvate enzyme complex is an analogue of the enzyme substrate complex.
If complex A is formed, its conversion to complex B must be very rapid
because it has not been detected with the native substrate.
It is possible that the oxidation and hydrolysis of ketimine B is
the rate limiting step in the mechanism, and therefore, the concentration of

B~)A.

This could aocount for the fact that a borohydride

reduced ketimine A complex has not been isolated.
The bacterial enzyme has a K of 8 mM with an optimum activity at
m
pH 5.9 (Westheimer, 1963). The enzyme has a high specificity for
acetoacetate; it has no action on alpha or other beta keto acids.

The

compounds so tested include acetopyruvate, acetone dicarboxylate,
oxaloacetate,

~-ketoglutrate

and pyruvate.

Phenylacetoacetate will

serve as a substrate, but the enzyme has a poorer K (10 ~), than the
m
native substrate acetoacetate (Fridovich, 1972).
Acetoacetate decarboxylase is inhibited by structural analogues of
the substrate, by compounds that interfere with the formation of a
Schiff base and by numerous monovalent anions.
analogue of acetoacetate, has a KI of 10

~·

Acetone sulfonate, an
The analogue reacts with

the enzyme to form an enzyme-substrate complex, but it will not be
converted to an enzyme-product complex {Fridovich, 1968).

The inhibitor

11

will support the reduction of the analogue-enzyme complex.

This is very

interesting because the borohydride reduction of labeled acetoacetate
in the presence of acetoacetate decarboxylase occurs only in the enzymeproduct complex.

This indicates two things, first, the Schiff base inter-

medtate is confirmed, and secondly, the decarboxylation step is very
rapid.

Thus, in the mechanistic scheme shown earlier, the steady state

conditions must favor very high levels of the enzyme-product complex as
compared to the enzyme-substrate complex (B>> A).
Beta diketones are very potent inhibitors of acetoacetate decarboxylase.

They will protect the enzyme against reduction by borohy-

dride in the presence of acetoacetate.

The ability of beta diketones

to inhibit the enzyme develops rather slowly.

This indicates that there

is an association of the diketone with the active site.

The

bindi~g

of diketone to the active site prevents the borohydride reduction.
Beta diketones form carbon to nitrogen bonds which are electron-rich
and, therefore, not reducible by borohydride.

'I'he essential feature of

inhibitor:r beta diketones is:
0
II

CH -C-CH -R
3
2
where R is some electron withdrawing group.

Acetylacetone and aceta-

pyruvate, two of the simplest diketones, inhibit the enzyme by forming
a ketimine between the epsilon amino group of lysine and the carbonyl
group adjacent to the methyl group.
borohvdride reduction.

Both inhibitors will prevent the

Removal of the inhibitors by dialysis results in

a recovery of the enzymatic activity.

Lineweaver-Burk plots demonstrate
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that the inhibition by acetylacetone and acetopyruvate is competitive
(Tagaki et. al., 1968; Autor and Fridovich, 1970a).
Monovalent anions will inhibit the activity of acetoacetate
decarboxylase.

The inhibition is due to the binding of the anions to

a cationic Schiff base salt.
include:

Four characteristics of the inhibition

(a) The cationic site behaves such that the pKa is 5.8 or

that consistent with an ammonium salt residue; (b) Binding sites indicate that one anion per site is sufficient to cause a loss of activity.

An increase in temperature will cause a decrease in the potency

of inhibition by bromide; (c) There appears to be a critical ionic
volume necessary for the inhibition by monovalent anions.
size increases from F- to Cl

As the ionic

to Br-, the entropy for the reaction of

the anion with the sensitive enzymic site becomes increasingly negative;
further increase in ionic size going from I- to 010 - to Bro - to ro 3
3
3
causes a reversal of the trend; (d) Divalent anions do not appreciably
inhibit the enzyme (Fridovich, 1963).

Table 1 lists a series of anions

and the concentration of each anion required to cause 5o% inhjbition of
the decarboxylation of 0.027

~acetoacetate

at pH 5.2 and at 30·c.

Acetoacetate is produced chiefly in the liver and to some extent in
the kidneys by a reaction in which acetyl coenzyme A reacts with
acetoacetyl coenzyme A to form 3-hydroxy-3methyl glutaryl coenzyme A
(Figure 1).

The acetyl coenzyme A and acetoacetyl coenzyme A arise

from the catabolism of fatty acids and ketogenic amino aclds.
'3-Hydroxy-3 methyl-glutaryl coenzyme A is cleaved to produce acetyl
coenzyme A and acetoacetate.

Acetoacetate can undergo one of two
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Table 1
Inhibition Of Acetoacetate Decarboxylase By Monovalent Anions.*
Anion

Concentration for 50% Inhibition
7 X 10-5
11 X 10-5

73 X 10-5

C10 4

I-

100 X 10-5

N0

3

126 X 10- 5

C103-

400 X 10-5
1,000 X 10-5
5,000 X 10-5
7,600 X 10-5
10,000 X 10-5
10,000 X 10-5

Tricholoroacetate

Fridovich, I.

(1963)

33,000 X 10-5

M

~ormation

of Acetoacetate

I
CH C

0

0

I!
- CH C -8CoA + CoASH

3

2
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acetyl CoA
OH

I

I
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I
I

0

L~
I

-CH

I
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reactions; it can be reduced to J-hydroxybutyrate or decarboxylated to
acetone and carbon dioxide.

The oxybutyrates, acetoacetate and

J-hydroxybutyrate are transported in the blood to target tissues chiefly
skeletal and cardiac muscle (Figure 2).
ybutyrate is oxidized to acetoacetate.

In the target tissues J-hydroxAcetoacetate is converted to

acetoacetyl coenzyme A in the presence of succinate-acetoacetate CoA
transferase, a pathway that appears to be minimal or absent in the liver.
The acetoacetyl coenzyme A thus formed is cleaved by yielding 2 molecules of acetyl coenzyme A which then enter the citric acid cycle.
Many biochemistry textbooks cite the decarboxylation of acetoacetate to occur nonenzymatically or spontaneously (West, Todd, Mason,
van Bruggen, 1966; Bhagvan, 1974; Karlson, 1975; Stryer, 1975; Harper,

1977; Montgomery, Dryer, Conway, Spector, 1977).

Several textbooks

make no comments on the specifics of the reaction (Mahler and Cordes,

1966; McGilvery, 1979; Bohinski, 1973; Cantarow and Trumper, 1975; Orten
and Neuhaus, 1975; Conn and Stumpf, 1976).

Only a few textbooks cite

the reaction to occur enzymatically (Rafelson, Binkley, Hayashi, 1971;
White, Handler, Smith, Hill, Lehman, 1978).
Acetoacetic acid is a weak acid and during the overproduction of
oxybutyrates as in the ketotic state, it will contribute to lowering the
blood pH.

The iowered blood pH causes vascular damage often associated

with the uncontrolled diabetic.

During the decarboxylation of aceto-

acetate, there is the uptake of a proton, lowering the proton pool.

The

decarboxylation of acetoacetate thus helps combat the falling blood pH.
Van Stekelenburg and Koorevaar (1972) have presented evidence that
human blood serum has acetoacetate decarboxylase activity.

All studies
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by Van Stekelenburg and Koorevaar were conducted by measurine; the rate
of acetone production by head space vapor gas chromatography.

Blank

or control solutions containing only acetoacetate in Tris buffer,
pH 7.4, were always run to determine the extent of nonenzymic decarboxylation.

Fifty-six random serum samples were collected and assayed

for their acetoacetate decarboxylase activity.
-1
se~:t

was 62.2.! 12.9 (S.D. )!".mole min

The mean activity pre-

-1
1

of acetone formed.

Interest-

ingly, all fifty-six samples demonstrated acetoacetate decarboxylase
activity.
Characterization of acetoacetate decarboxylase activit'r in human
serum was first based upon a molecular weight study (Van Stekelenturg
and Koorevaar, 1972).

Serum samples were subjected to ul trafi ltra t ion

accelerated by centrifugal force.
membrane was 30,000.

The molecular weight cut-off of the

After separation, the retentate was washed with

physiological saline and the initial volume reestablished.

The filtrate

and ret.entate were assayed for acetoacetate decarboxylase act.ivjt;.

The

filtrate did not demonstrate ar'Y acetoacetate decart.oxylase act. i. vj ty,
while the retentate contained all the activity initially observed.

Thus,

the activity in human serum is not due to any ions, small proteins or
peptides; the molecular weight of the active component is greater than
30,000.
The acetoacetate decarboxylase activities of different humar, serum
protein fractions have been tested (Van Stekelenburg and Koorevaar, 1972).
The albumin fraction showed by far the greatest amount of activity.

The

globulins demonstrated activity but only a fraction of that seen for
albumin.

The albumin contents of the different globulin fractions were
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determined immunochemically by the Ouchterlony plate technique.

By

assuming the activator present in human serum is albumin-like or albumin
itself, the activities present in the globulin fractions could be
corrected for the albumin impurities present.

By determining the amount

of albumin and calculating the activity associated with that amount of
albumin, these workers concluded that the globulins do not exhibit significant acetoacetate decarboxylase activity.
The influence of pH of the incubation medium upon the acetoacetate
decarboxylase activity of purified human albumin was also investigated
(Van Stekelenburg and Koorevaar, 1972).

Optimal activity occurs at pH

4.5; however, a considerable fraction of the activity is still present
at pH 7.4.
The influence of substrate concentration was studied by evaluating
the K at pH 5.0 and pH 7.4.
m

Albumin demonstrates a very poor binding

constant which is not affected by the change in pH (Van Stekelenburg
and Koorevaar, 1972).

The Km was estimated to be 0.4

~·

The effect of temperature upon the acetoacetate decarboxylase activity of albumin was also studied by Van Stekelenburg and Koorevaar (1972).
Purified albumin diluted with physiological saline was heated at so·c
for 15, 30 and 60 minutes respectively at pH 7.4.

After 15 minutes,

there was a 35% loss of activity, at 30 minutes a 45% loss and at 60
minutes a 55% loss of activity.
fraction is not heat stable.

The active component of the albumin

Autor and Fridovich (1970b) reported the

thermal inactivation of bacterial acetoacetate decarboxylase to occur in
the temperature range of 74-82·c.

Heating at so·c for 30 minutes will

cause a 5o% decrease in the activity of the bacterial enzyme.

Thus,
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there is a good correlation between the heat inactivation of bacterial
and mammalian acetoacetate decarboxylase activity.
Human serum albumin has been subjected to various inhibitors of
bacterial acetoacetate decarboxylase.

Davies (1943) showed that the

bacterial acetoacetate decarboxylase would be totally inactivated in the
presence of a 10-5 ~ concentration of HgC1 •
2

Van Stekelenburg and

Koorevaar (1972) observed no loss in activity with HgC1

2

at 10~ , 10~

or 10-3 ~; however, at 1o-2 ~' the decarboxylase activity of albumin was
inhibited by 76%.
The influence of monoiodoacetate upon the acetoacetate decarboxylase activity of purified albumin has been studied.

At a concentration

of the inhibitor of 10 ~' 74% inhibition was found (Van Stekelenburg
and Koorevaar, 1972); at the same concentration, the bacterial enzyme
activity is inhibited by 6)% (Davies, 1943).
Urea will also inhibit the acetoacetate decarboxylase activity of
the albumin fraction (Van Stekelenburg and Koorevaar, 1972).

In the con-

centration range of 0-10 M, the highest inhibition attained was 45% and
at 10 M.

The active component can be denatured and inhibited to some

extent, but very high concentrations of urea are necessary.
centration of 10

~

At a con-

urea, 45% inhibition of activity was attained.

The effect of increasing concentrations of EDTA (ethylenediaminetetraacetic acid) upon the activity of purified albumin has been studied
(Van Stekelenburg and Koorevaar, 1972).
trations, 1-3
Above 3

~'

~'

Interestingly, at low concen-

there is an activation of the decarboxylase activity.

inhibition is observed; this reaches a maximum of 30% at
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9

~·

No explanation has been given as to why a chelating agent will

increase the acetoacetate decarboxylase activity of the purified albumin.
In contrast to the findings of Davies (1943), Van Stekelencurg and
Koorevaar (1972) observed no inhibition of acetoacetate decarboxylase by
pyruvic acid.

The concentration range employed for pyruvic acid was

similar to that used for the bacterial enzyme studies.

In all previous

inhibition studies by these workers, the concentration needed to inhibit
the decarboxylase activity of albumin was always greater than that required to inhibit the bacterial enzyme.

It is not known why Van

Stekelenburg did not increase the concentration of pyruvic acid.
Vitamin B (lactoflavin) acts as an activator for the decarboxylase
2
activity observed in purified human albumin.
greater than that observed with EDTA.

The activation is much

However, like EDTA, as the con-

centration increases, there is a reversal in the role of vitamin B •
2

At

a lactoflavin concentration of 1 )lg/ml, the original activity is doubled.
Above 1 yg/ml, the activity declines until at 6 )lg/ml of lactoflavin
the reaction is inhibited by

40%.

Koorevaar and Van Stekelenburg (1976) performed an extensive study
of the reaction kinetics for the decarboxylation of acetoacetate in the
presence of Fraction V human serum albumin.

The relationship between

the enzymatic activity and substrate concentration was found to be
sigmoidal in nature.

The reaction deviates from normal Michaelis-Menten

kinetics and, therefore, the K has been estimated to be equal to or less

m

than 0.1

~·

The binding constant is better than reported earlier

(Van Stekelenburg and Koorevaar, 1972); however, it is still very poor.
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Even though the minding constant is poor, albumin still demonstrates
reaction kinetics.
Seeley (1955) reported that rates of decarboxylation of acetoacetate
are increased in the presence of organ extracts.

Koorevaar and Van

Stekelenburg (1976) investigated whether this effect could be due to the
presence of mild reducing substances in the incubation medium.

Decarbo-

xylase activity was determined in the presence and in the absence of
glutathione and cysteine.

It was found that the reducing agents did in-

crease the rate of non-enzymatic decarboxylation of acetoacetate, but
had no effect upon the activity associated with the albumin fraction
tested.

Thus, the increased decarboxylation rates observed by Seeley

(1955) could be due to the presence of small organic SH-group containing
substances in the organ extracts.
Because of the well known microheterogeneity of albumin (Hughes,

1964), Koorevaar and Van Stekelenburg investigated whether or not there
is a localization of acetoacetate decarboxylase activity within one of
the various albumin subfractions obtained by column chromatography.
Human albumin (Mann Research Laboratories, cat #1702) was passed through
a Sephadex G-200 column.

Three peaks containing protein were resolved.

The peaks were reported to represent the monomer, dimer and trimer (and
higher polymers) of albumin.

Each peak was divided into subfractions

and assayed for decarboxylase activity.

The specific activity of the

subfractions was found to be homogeneous.

It was concluded that the

acetoacetate decarboxylase activity is bound tightly to the albumin
molecule and that the

en~matic

activity does not depend upon the degree

of polymerization of the albumin molecule.
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To obtain further evidence on the coupling of the decarboxylase
activity to albumin, Koorevaar and Van Stekelenburg (1976) subjected
Fraction V human serum albumin to ion exchange chromatography with DEAE
Sephadex A-50.

Two peaks were obtained from the elution.

One peak con-

sists of mercaptalbumin, while the other was considered to be a mixture
of non-mercaptalbumin and polymers of albumin.
was found to exhibit low specific activity.

The mercaptalbumin peak

It is possible that the ac-

tivity present in the mercaptalburnin peak is due to the contamination of
non-mercaptalbumin and polymers of albumin.

The non-mercaptalbumin peak

was divided into two subfractions and shown to contain a high specific
activity.

It was concluded that the free SH-group of mercaptalbumin

interferes in some way with the acetoacetate decarboxylase activity.
Koorevaar and Van Stekelenburg (1976) assayed fifty-six serum samples
obtained from patients ohosen at random and found a positive correlation
between the acetoacetate decarboxylase activity and the corresponding
albumin concentration of the patient.

In the study of the fifty-six sera,

43 specimens showed specific activities within the range found for purified human albumin (1.49! 0.18 (S.D.) )lmole min-1 g albumin -1) , with a
-1

mean value of 1.48 umole min

significant deviations from the mean.
tained were:

-1

g albumin

The remaining sera showed

Some of the extreme values ob-

an oligophrenic patient, with hypertelorisma, 0.6JJ a

patient with a mild compensated, metabolic acidosis 0.80; a ketotic
diabetes mellitus patient, with decreased kidney function 0.94: a patient
with collagenosis 1.11; a patient who died from a hemolytic uremic
syndrome 2.1); and a ketotic diabetes mellitus patient with a nephrotic
syndrome ).85 umole min-lg albumin -t.

It is not known why differences
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exist for the patients in the disease states mentioned above.
Acetoacetate decarboxylase activity has also been observed in
mammalian organ extracts (Koorevaar and Van Stekelenburg, 1976).

Liver,

kidney and brain from adult male rats were homogenized and subsequently
fractionated.

Five fractions were obtained:

2. the nuclear fraction;
and

5.

the supernatant.

J.

1. the original homogenate;

the mitochonodria; 4. the lysosome fraction

1
The specific activity (pmole min- g protein- 1 )

of the original brain homogenate was found to exceed that of kidney and
liver.

With respect to the liver, the specific enzyme activities do not

differ much for the tissue fractions except for the nuclear fraction
whose specific activity was very low.

The kidney had approximately the

same specific activity in all fractions with the exception of that of the
mitochondrial fraction which was very low.

Brain tissue was found to

contain its highest specific activity in the nuclear fraction, and
higher as well when compared to the values obtained for the tissue fractions of liver and kidney.

No explanation has been given for the

different activities observed among the subfractions of the organ extracts.
Generally, in the schemes of mammalian biochemical pathways, the
decarboxylation of acetoacetate is said to occur nonenzymatically,

From

experiments by Koorevaar and Van Stekelenburg (1976) the nonenzymatic
decarboxylation of acetoacetate at pH 7.4 and J7"C appears to be a first
order reaction.

In a blank or control sample, it has been calculated

that 0.65,% of the original acetoacetate present is decarboxylated in one
hour.

In the presence of a normal serum, a decarboxylation velocity of

1).5% of the original substrate concentration per hour was found.

Based

~

upon this fact, these workers believe that the nonenzymatic decarboxylation of acetoacetate is of no, or minor, biochemical significance.
Peters (1970), in a lengthy review of serum, states that albumin
has many functions and raises the question, are there undetected
functions?

Koorevaar and Van Stekelenburg (1976) believe that albumin

has another function; to help defend the body against ketosis.
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Statement of the Problem
Van Stekelenburg and Koorevaar (1972) have given evidence that the
decarboxylation of acetoacetate in mammalian syGtems may occur enzymatically.

Human serum albumin seems to possess

en~matic

properties

which are similar to those observed for the bacterial enzyme acetoacetate decarboxylase.
vity that:

The human serum albumin fraction demonstrates acti-

(1) is not ultrafiltrable, (2) has an optimum pH of 4.5,

(J) has enzyme-like substrate dependency, (4) is inhibited by monoiodoacetate, urea and HgC1 , (5) exhibits heat instability at
2
(6) is activated by lactoflavin.

so·c

and

From fractionation studies of human

serum albumin by means of gel filtration with Sephadex G-200, it has been
concluded that the degree of polymerization has no effect upon the
acetoacetate decarboxylase activity (Koorevaar and Van Stekelenburg,
1976).

Homogenates and the subfractions of rat brain, liver and kidney

tissues were shown to possess acetoacetate decarboxylase activity.
The dissertation study has investigated four aspects of the decarboxylation reaction.

First, Van Stekelenburg reported in 1972 that rat

liver homogenates possessed acetoacetate decarboxylase actjvity.

To

follow this aspect, a partial purification of acetoacetate decarboxylase

was attempted from bovine liver.

Second, the inducibility of the

enzymatic activity was determined by placing rats under the stress of
ketosis.

Rats were made diabetic with streptozotocin and their acetoace-

tate decarboxylase activity was monitored in plasma samples.

Third,

further characterization of the acetoacetate decarboxylase activity was
performed on sgmples of Fraction V human serum albumin.

Fourth,

experiments were performed to gain insight into the mechanism of
decarboxylation of acetoacetate by albumin.

CHAPTER II
MATERIALS AND METHODS
Assay of Acetoacetate Decarboxylase.
Acetoacetate decarboxylase activity was measured by following the
production of acetone from the lithium salt of acetoacetate by head
space vapor gas chromatography (Van Stekelenburg and DeBruyn, 1970).
To control extraneous activity or breakdown of acetoacetate, recommendations suggested by Van Stekelenburg and Koorevaar (1972) were taken into
consideration.

(1)

Acetoacetate is chemically unstable; therefore, it

is necessary to measure the nonenzymatic decarboxylation of substrate in
each experiment (blank experiments).

(2)

To maintain conditions of

equilibrium between the acetone concentration in the vapor and in the
aqueous phase, all experiments were carried out in a shaking waterbath
thermostated at

37'C.

(3) The acetone concentration in the vapor phase

depends not only upon the concentration of acetone in the aqueous phase,
but it also depends upon the osmolality of the aqueous phase.

(4)

In

general, the acetoacetate decarboxylase assays were run for four hours
and the concentration of acetone was determined five or six times during
the incubation period.
The acetoacetate decarboxylase reaction was carried out in 40 ml
rubber-stoppered vials.

The reaction mixture contained 2.7 ml of

Tris buffer, pH 7.4, 0.1 ml of 0.45
the test material.

~lithium
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~

acetoacetate and 0.2 ml of

Head space samples were withdrawn by puncturing the
27
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rubber stopper with a 1 ml air-tight syringe (Pressure LuK, Series A-2
Precision Sampling, Baton Rouge, Louisiana).

The 1 ml head space

sample was compressed to 0.1 ml and injected into the gas chromatograph.

The syringe must be purged with extra-dry nitrogen after each

injection to ensure that there is no build-up of residual acetone.
The gas chromatograph used was either a Varian 2440 or a BarberColman Model 5320.
ionization detector.

Both gas chromatographs were equipped with a flame
The Barber-Colman gas chromatograph had an alu-

minum column, 6 ft. in length with an internal diameter of 1/4 inch.
The injection port temperature was 220'C, the column oven temperature
was 160'C, and the detector temperature was 220'C,

The Varjan model

had a glass column, 6 ft. in length with an internal diameter of 1/8
inch.

The injection port temperature was 250'C, the column oven temper-

ature was 170'C, and the detector temperature was 290'C.

The columns of

both gas chromatographs were packed with Porapak QS resin, 80-100 mesh
(Anspec Company, Inc. Ann Arbor, Michigan).
columns was zero grade nitrogen (Linde),

The carrier gas for both

The gas flow of nitrocer,

hydrogen and air was 30 ml, 20 ml and JOO ml/min, respectively.
Standard solutions of reagent grade acetone (Mallinckrodt, St. Louis,
Missouri) were prepared containing 15, 30, 60 and 90.1"6 of acetone
respectively in J ml of aqueous solution,

The relationship between the

concentration of acetone and the peak height in mm was found to be linear
over the range described,
Before an assay was performed, the validity of the standard curve
was checked by three injections of the

90~g

standard.

The peak
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heights must be monitored closely since the columns lose sensitivit:;
with time.

A new standard curve was prepared when the peak height

determined after an incubation time of four hours for the 90 pg standard
varied more than

5 mm from the previously determined value.

Porapak QS is a pure white resin.
resin begins to turn brown.

After two months of use, the

The brown color is readily observed through

the glass column; and when seen, the cmlumn is repacked.

The status

of the aluminum column is checked by monitoring the retention time of
the acetone.

When the retention time increased by thirty seconds, the

column was emptied and repacked with fresh resin.
For the assay of experimental samples for acetoacetate decarboxylase activity, the total change of the acetone concentration in the vapor
phase expressed in mm of peak height per unit of time minus the change
of the acetone concentration in the vapor phase of the corresponding
blank experiment is a measure of the enzyme activity.

The acetoacetate

decarboxylase activity was expressed in terms of units.

One unit of

activity is defined as the production of lpmole of acetone per minute
per gram of protein.

An example of a typical plot for the determination

of acetoacetate decarboxylase activity of Fraction V human serum albumin
is presented in Figure

J.

In all experiments described in the disser-

tation, the source of Fraction V human serum albumin was Miles Laboratories, Elkhart, Indiana (Code no. 82-302, Lot no. 141).
the albumin was stated to be
electrophoresis in a 75

~

The purity of

96% as determined by cellulose acetate

baribital buffer, pH 8.6.

Figure 3. Acetoacetate decarboxylase assay by head space vapor gas
chromatography.
The graph shows the increase in the acetone concentration (in mm
peak height) of head space vapor during a typical acetoacetate decarboxylase assay. The blank reaction mixture contains 2.7 ml of 50 ~
Tris buffer, pH ?.4, 0.1 ml of 0.45 M lithium acetoacetate and 0.2 ml
of deionized water. The sample reaction mixture contains 2.7 ml of
50 mM Tris buffer, pH ?.4, 0.1 ml of 0.45 M lithium acetoacetate and
10 mg of Fraction V human serum albumin in-0.2 ml of deionized water.
The difference in peak height between the blank and albumin sample is
related to the acetone concentration by use of a predetermined standard
curve.
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Preparation of Labeled and Unlabeled Lithium Acetoacetate.
Lithium acetoacetate, the substrate for the acetoacetate decarboxylase assay was prepared according to the method of Hall (1962).

The

unlabeled substrate was prepared from ethyl acetoacetate (Fisher
Scientific Company, Fair Lawn, New Jersey) while the labeled substrate
was prepared from ethyl-0-

14
c)-acetoacetate (Amersham Corporation,

Arlington Heights, Illinois),
prepared in the same way.
acetate,

The labeled and unlabeled substrates are

A mixture of

25 ml water and 10.0 ml of 4.00

5.2 g (0.04 mole) ethyl aceto~

LiOH was placed in a cork-

stoppered Erlenmeyer flask and incubated at 40'C for four hours.

A pale

yellow solution resulted, and it was evaporated to dryness under reduced
pressure at a bath temperature of 40'C,

It is essential that the flask

contents be completely dry, otherwise the subsequent crystalization of
the compound from a methanol-ether mixture is difficult.

The crude

lithium acetoacetate was extracted at room temperature from the dry
crystalline mass with three successive 15 ml portions of absolute
methanol.

Insoluble material was removed by passage of the mixture

through a Whatman no. 4 filter paper.

Absolute ether was added slowly

to the clear methanol filtrate until the solution became slightly turbid.
The mixture was allowed to stand at room temperature for

JO

minutes.

Five volumes of ether were added slowly to the mixture which was then
chilled to 4'C,

The crystals were collected by suction filtration,

washed with ether and dried in vacuo.

The product was recrystallized

twice by redissolving the material in absolute methanol (6 ml per gram)
removing insoluble material by filtration and adding absolute ether as
before.

The yield based on ethyl acetoacetate was 50-60%.
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The purity of the lithium acetoacetate was determined from absorption spectra.
in 0.1

~

HC1.

The measurements were taken in water, in 0.1

~

NaOH and

The spectra were obtained with the use of a Model DB-G

Beckman Spectrophotometer.

The concentration of the lithium acetoacetate

in all three media was 4.00

~;

the light path was 1.00 em.

The molar

extinction coefficients at the peak absorptions of 273, 267 and 247 nm
2
were respectively 47,0, 147.5 and 72.5 cm •

Hall (1962) reported molar

extinction coefficients at the same peak absorptions of 50.0, 148.0
2

and 73.0 em respectively.
The crystalline lithium salt of acetoacetate is non-hygroscopic
and is stable for several months when kept under vacuum at 4"C.

Neutral

solutions of the lithium salt may be frozen at -10"C for 2-3 weeks
without significant decomposition.
Protein Determination.
Protein was determined by utilizing the colorimetric method of
Lowry et. al., (1951) as modified by Oyama and Eagle (1951).

There are

two distinct steps which lead to the final color development with protein:
(1) a reaction with copper in alkali, and (2) a reduction of the phosphomolydic-phosphotungstic acid reagent by the copper-treated protein.
One ml of reagent "C" was placed in each of a series of 10 X 75 mm
polystyrene test tubes.

Two hundred

pl

of sample was added to appropri-

ately marked tube and two hundredpl of deionized water was added to a
blank tube.

The contents of the tubes were mixed and allowed to stand

for ten minutes.

One hundred

pl

of Folin-Ciocalteu reagent (Hartman-

Leddon Company, Philadelphia, Pa.) was added to each tube and the tubes
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were mixed thoroughly.

The reaction mixtures were allowed to stand for

30 minutes to allow for full color development.

The absorbance of the

sample solutions was determined with a Beckman DU spectrophotometer at
a wavelength setting of 750 nm.
instrument.

A standard

The blank tube was used to zero the

curve was prepared following this procedure

using Fraction V bovine albumin powder (Pentex Biochemicals, Kankakee,
Illinois) as the standard.
The concentration of the unknown sample is calculated by using the
formula:
Hg protein
ml of unknown sample

= absorbance

of unknown Xconcentration X
5
absorbance of standard of standard
~~

The data for the calibration curve are given in Table 2 and the standard
curve is shown in Figure 4.
Solutions
1.

Reagent A
20 g of Na co , 4 g of NaOH and 200 mg of KNa c H o · 4H o
2 3
4 4 6
2
were dissolved in one liter of deionized water.

2.

Reagent B

5 g of Cuso4 • 5H 20 was dissolved in one liter of deionized
water.

3. Folin-Ciocalteu Reagent
Folin-Ciocalteu Reagent was obtained from the Hartman-Leddon
Company and diluted with deionized water in the ratio of 5
parts of the phenol reagent to 7 parts of deionized water as
recommended by ~]ama and Eagle (1956),
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'Table 2
Standard Curve Data For Protein Determination
Albumin (pg)

Number of
Determinations

Absorbance*
750 nm

5

6

0.066 + 0.002

10

6

0.124 + 0.001

20

6

0. 231 .! 0. 003

30

6

0.323.! 0.003

40

6

0.408 + 0.002

50

6

0.497.! 0.006

* Mean .! standard deviation.
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4.

Reagent C
Fifty parts of reagent A and one part of reagent B were
mixed freshly prior to use.

Determination of Plasma Glucose
During the course of this study, it was of interest to determine
whether acetoacetate

activity was inducible during star-

decarbo~Jlase

vation or in the diabetic state.

For the latter purpose, streptozotocin

(Upjohn Company, Kalamazoo, Michigan) was used to induce diabetes
mellitus in fed adult male

rate~

The blood was collected from the tail vein while the animals were
lightly anesthetized with sodium pentobarbital, 32.5 mg/kg of body
weight, injected intraperitoneally.
backs and taped into position.

The animals were placed on their

The tip of the tail was snipped and the

blood was collected in Natelson heparinized micropipettes.

The tail was

milked to facilitate collection of the blood and prevent the formation
of a clot.

Three Natelson pipettes were filled before the bleeding was

stopped.
The plasma was obtained from the Natelson micropipettes by flaming
shut the opposite end of the pipette used to introduce the blood.

The

closure allows the blood to be centrifuged in the pipettes without
unnecessary transfer and possible loss of plasma.
centrifuged at 2000 rpm for 15 minutes.
were cut near the plasma/RBC junction.

The pipettes were

After centrifugation, the pipettes
The plasma was transferred to

test tubes and frozen until assayed.
The glucose levels were monitored with a Beckman Glucose Analyzer
(Beckman Instruments, Inc., Fullerton, California).

The analyzer

J7
employs an oxygen sensitive electrode and an electronic system that measures the rate of change in oxygen concentration when a sample is injected into an enzyme solution.

Plasma is introduced into a sample cup

containing glucose oxidase. ~ -D-glucose in the plasma combines with
the dissolved oxygen in the solution according to the reaction:
~

~

-D-Glucose +

2

glucose

o ~o~x-i~d~a-s~e---)+

The oxygen is consumed at the same rate as the glucose reacts and, therefore, the rate of oxygen consumption is directly proportional to the
glucose concentration.

Because oxygen consuption rather than peroxide

formation is measured, peroxide must be destroyed by a path not leading
back to oxygen.
of two ways.

The destruction of peroxide can be accomplished in one

In the presence of catalase, ethanol reacts with hydrogen

peroxide according to the following reaction:
catalase

)

Acetaldehyde + 2H

o

2

Also, peroxide may be decomposed in the presence of iodide and molybdate
ions according to the equation:

molybdate

}

The enzyme reagent solution contains, in addition to the enzyme glucose,
oxidase, ethanol, catalase, iodide and molybdate to ensure that a
complete destruction of the generated peroxide is accomplished.
Isoelectric Focusing
In electrophoresis, the pH of the stationary phase is constant
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throughout.

Thus, proteins migrate according to the charge they possess

at that pH.

In isoelectric focusing, there is a pH gradient established

by commercially available ampholytes.

When current is applied to an

isoelectric focusing column, proteins will migrate to a position in the
pH gradient where the net charge they possess is zero.
themselves in distinct bands.

Proteins layer

At the end of the electrophoretic run, the

effluents from the column are passed through a monitoring device and
collected with a fraction collector.
The pH gradient, which is the basis for isoelectric focusing, is
established by aliphatic polyamino-polycarboxylic acids.

These compounds

have small differences in pi when compared to each other.

At the beginn-

ing of a run, the pH of the column is the average value for all the
carrier ampholytes in solution.

When current is applied to the column,

the ampholytes migrate to a position where their net charge is zero.
To prevent disruption of the pH gradient by convection, the column
is stabilized by a sucrose density gradient.

The column is prepared by

mixing the carrier ampholytes and sample proteins in the sucrose solution.
The sucrose solution is then layered on the column using a gradient mixer.
After current is applied to the column, it is necessary to protect
the carrier ampholytes located near the electrodes from anodic oxidation
and cathodic reduction.

This is done by surrounding the anode with an

acid solution and the cathode with an alkaline solution.

The carrier

ampholytes at the anode become positively charged and these are repelled
from the anode.

At the cathode, the ampholytes become negati.vely charged

and are repelled away from the cathode.
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Partially purified bovine liver extracts were applied to isoelectric focusing columns.

The entire electrofocusing column (LKB 8100

Ampholine Column, LKB Instruments, Inc., Rockville, Maryland) was thermostated at 4"C by utilizing a cryostat (Tamson Thermostatic Path (TM-9)
and circulator (PBC-4, Neslab Instruments, Inc., Portsmouth, New Hampshire), which circulated coolant around both the inner and outer electrofocusing columns.

The coolant consisted of equal volumes of distilled

water and ethylene glycol.
14.6

~

The anode solution consisted of 0.2 ml of

phosphoric acid, 14 ml of distilled water and 12 grams of sucrose.

The anode solution was introduced through a side port in the column.

It

is important to ensure that the anode is covered by approximately one
inch of solution.

The sucrose gradient was prepared by dissolving 28

grams of sucrose in 42 mls of water and adding 3.75 ml of an LKB Ampholine with a pH range of J.5-10 (LKB Instruments, Inc., Rockville, raryland) to the solution.

The solution was heated gently and stirred to

facilitate the dissolution of the sucrose.
dense sucrose solution.

This solution is called the

A light solution was prepared by dissolving

1.25 mls of the LKB Ampholine to 60 ml of distilled water.

Five ml of

this solution was discarded (to accommodate the column volume) and 20 ml
of the bovine liver extract was added to the light solution.

The sucrose

gradient was established through the use of an LKB Gradient Mixer, Model
8121.

After the dense and light solutions were applied to the column,

the cathode electrode solution was added.

The cathode solution was pre-

pared by dissolving 0.20 grams of sodium hydroxide in 20 ml of distilled
water.

The cathode solution was layered on the sucrose solution until the

platinum cathode was covered by approximately 1 inch of solution.

A
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constant val tage of 500 val ts was applied to the column for a. period of
48 hours.

The power source was shut off and the bottom of the column

opened so that the effluent could be monitored and collected.

Monjtor-

ing was performed with a Uvicord Absorptionmeter and Recorder (L~J Instruments, Inc., Rockville, Maryland) and fractions were collected with a
Unifrac Fraction Collector (Savant Instrument Inc., Hicksville, New
York).

Fifty drop aliquots (3.8 ml) were collected until the column was

completely emptied.
The pH of the fractions was measured while cold with a Corning pH
meter, Model 12-B, (Corning Scientific Instruments, Corning, New York)
equipped with a Markson pH electrode (Markson Science Inc., Del Mar,
California).
Acylation of Human Serum Albumin
The mechanism of action for the bacterial enzyme occurs through the
formation of Schiff base between the carbonyl group of the acetoacetate
and a reactive lysine residue in the active site of the enzyme, (Warren
et. al., 1966).

To investigate whether albumin has a similar mechanism,

acylating agents such as succinic and citraconic anhydrides, were used to
block the epsilon amino groups of lysine.
Fraction V human serum albumin (Miles Laboratories, Inc., Elkhart,
Indiana) was acylated with succinic or citraconic anhydride
(2-methylmaleic anhydride).
reaction to occur as follows:

Klotz (1967) represents the acylation
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Jonas and Weber (1970) have demonstrated from fluorescence polarization measurements that the dicarboxylic anhydrides will expand the albumin molecule, due to electrostatic repulsion, but that the attachments
of acylating groups have no effect on the protein structure.

Thus,

modification of albumin by acylating agents would not be expected to
alter the acetoacetate decarboxylase activity.
The acylation of albumin by succinic or citraconic an.hydrjde was
carried out as described by Jonas and ~Jeber (1970).

Solid succlnvl an-

h~rdride (Eastman Kodak Company, Rochester, New York) was added slowly in

small amounts to a 1% solution of the human serum albumin with cor:tinuous stirring at room temperature.

During the reaction of succinic anh:r-

dride with the epsilon amino group of lysine, there is a release of protons,

The pH of the mixture is kept constant at

addition of 1 M NaOH.

7 by the drop-wise

The reaction was deemed complete when there occurred

no further drop in the pH of the solution upon the addition of succinlc
anhydride.

The unreacted succinic anh;.:dride, which in water is largely

hydrolyzed to succinate, was removed by exhaustive dial:sis.

After
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dial:: sis, the succinated albumin solution was lyophilized, reconstituted
with 2.0 ml of 50 mM Tris buffer, pH 7.4 and assayed for acetoacetate
decarboxylase activity.

The succinated albumin is a stable complex and

can be stored in the refrigerator for several days without decomposition.
The reaction of Fraction V human serum albumin with citraconic
anhydride (Aldrich Chemical Company, Inc., Milwaukee, Wisconsin) was also
carried out at room temperature with continuous stirring and manual adjustme:!'lt of pH with 1 M NaOH to pH 8.0.

The citraconyl protein is hv-

drol:rzed easily at pH values as high as 7 after several hours at room
temperature, but when kept cold at pH 8.0 is stable for a few da:1s
(Jonas and Weber, 1970).

To speed the removal of the unreacted citra-

conic anh·1dride and restrict undesired hydrolysis, the acylated protein
was passed through a Sephadex G-25 column (Fharmacia Fine Chemicals,
Inc., Piscataway, New Jersey) 2.5 X 30 em, equilibrated with 50 mfvl f'ris
buffer, pH 8.0.

Volume fractions of 130 drops (approximately 10 ml per

fraction) were collected with a Unifrac Fraction Collector (Savant
Instruments, Inc., Hicksville, New York).

The absorbance of the efflu-

ent was monitored at 280 rnrn with a Uvicord absorptionmeter and recorder
(LKB Instruments, Inc., Rockville, Maryland).
eluted in the void volume and in a broad peak.

The albumin complex was
Fractions containing the

acylated albumin were pooled and concentrated by lyophilization.

:!!:ach

albumin-complex sample to be tested was reconstituted with 2 ml of 50

m~

Tris buffer, pH 8.0 and assayed for acetoacetate decarboxylase activity.
After assay, the citraconyl albumin samples were hydrolyzed to
remove the acylating agent.

The reason for this approach was an attempt

to recover activity lost during the acylation.

If successful, this
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procedure would lend further support for a role of the free epsilon amino
group of lysine in acetoacetate decarboxylation.

Hydrolysis was performed

by placing the samples in 20 ml screw-capped vials with a stirring bar
and lowering the pH to 2.5 with 0.5

4'c.

mix overnight at

~

HCl.

The samples were allowed to

After hydrolysis, the samples were agajr. passed

through the Sephadex column to remove the 2-methylmaleic acid.

Ten ml

fractions were collected as previously described, concentrated by
lyophilization and assayed for acetoacetate decarboxylas'; acUYHy.
Determination of the Free Amino Group Content of Human Serum Albumin
The extent of acylation of Fraction V human serum albumin by
succinic and citraconic anhydrides was followed by utilizing the colorimetrlc ninhydrin assay of Matthews et. al., (1964) for the determinations of free amino groups.
0

Ninhydrin reacts with amino acids as follows:
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Colored l'roduct

In this reaction, the amino acid is oxidized to an
ing one less carbon atom.

aldeh~de

contain-

Ammonia and carbon dioxide are released.

true amino acids, peptides,

protei~s,

amino groups undergo this reaction.

All

or any compound containing free
In an acidic environment, one resi-

due each of reduced and oxidized ninhydrin condense with ammonia to form
a bluish colored reaction product.

The color developed differs with the

character of the protein, the amino acid or mixtures of the two.
'

The ninhydrin method is simple to perform and it is as specific as
the gasometric method

for~-amino

nitrogen (Matthews et al., 1964).

The

colored product formed during the reaction is measured spectrophotometrically at 570 nm.

The following reagents are needed for the assay:

Stock cyanide, 0.01

~

NaCN. -Dissolve 490 mg in 1 liter of water.

Cyanide -acetate buffer, pH 5.2. -To 190 g CH
500 ml water and dissolve.

sodium EDTA.
make up to

COONa · 3H 0 add
2
3
Add 36 ml glacial acetic acid and 5 g di-

Mix well, then add 20 ml of the stock cyanide solution.and

1 liter with water. Store at 4·c.

Methyl cellosolve (ethylene glycol monomethyl ether) - The reagent
should give a negative peroxide reaction with

10%

KI, and a clear

solution on mixing with water.
Ninhydrin reagent - Ninhydrin Jfo (w/v) in methyl cellosolve. Store
at 4'C,
Stock standard amino acid solution -Dissolve 536 mg gl::cine in 100
ml water (= 100 mg of NH N per 100 ml).
2
store at 4·c.
Working standard - Dilute

Preserve with chloroform and

5 ml of stock standard to 100 ml with

water on the day of the estimation.

Diluent - Isopropanol, mixed with an equal volume of water.
Procedure:
1.

Into a series of 18 X 150 mm pyrex test tubes was added 0.9 ml of
deionized water.

2.

To the appropriate tubes was added 100 pl of unknown solution or of
deionized water.

Next

0.5 ml of the cyanide-acetate buffer and 0.5

ml of ninhydrin reagent were added.

The solutions were mixed, capped

with aluminum foil and placed in a boiling water bath for 15 minutes.
The tubes were then removed and cooled by immersion in cold water.
To each tube, 15 ml of diluent was added.

The tube contents were

mixed by inversion and read against water at 570 nm in 1 em cuvettes
at a Beckman DU Spectrophotometer.
A standard curve was prepared following this procedure,

The data

for the standard curve are given in Table 3 and the standard curve is
shown in Figure

5.

Borohvdride Reduction of a Postulated Schiff Base Intermediate Formed
Between Acetoacetate and Human Serum Albumin
The bacterial acetoacetate decarboxylase enzyme catalyzes the decomposition of acetoacetate by forming a Schiff base wi.th the substrate.
Schiff base intermediates formed between the bacterial enzyme and acetoacetate can be reduced by borohydride (Fridovich and \·iestheimer, 1962).
The enzyme is inactivated by this treatment.

To ascertain whether the

mechanism of action of the acetoacetate decarboxylase activity associated
with Fraction V human serum albumin involves Schiff base formation, a
borohydride reduction was performed with a radioactively labeled substrate
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TABLE 3
Standard Curve Data For The
Determination Of Free Amino Groups

NH -N
2
(;.tg)

Number of
Determinations

Absorbance*
570 nm

2.5

3

0.228 + 0.003

5.0

3

0.453.! 0.003

?.5

3

0.680 + 0.00()

10.0

3

o. 900

* Mean

! standard deviation.

.!

o. 000
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Standard curve for alpha amino nitrogen determination
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(3- 14C) -acetoacetate.

Reduction occurs if a carbon-14 labeled altumin

complex is obtained from the reaction mixture.

Formation of a labeled

albumin complex offers evidence for the involvement of a Schiff base
intermediate in the mechanism of action of the enzyme.
Ten mg samples of Fraction V human serum albumin (Miles Laboratories,
Elkhart, Indiana) were dissolved in 2.9 ml of
and placed in

25

ml Erlenmeyer flasks.

brought to 37'C in a shaker water bath.

The

50 mtl Tris buffer, pH ?.4

conte~ts

of the flasks were

One hundred micro-liters of

0.45 _!:! (3- 14c) aceteacetate (5.06 X 105 dpm) (New England J!uclear, Boston,
Massachusetts) was added to each flask.
37'C for 30 minutes.

All flasks were incubated at

During the incubation period, 30 and 60 mM solu-

tions of sodium borohydride (J. T. Baker Chemical Co., Phillipsburg,
r;ew Jersey) were prepared in 10 ml of 1

mM sodium hydroxide.

Sodium

borohydride is unstable in aqueous solution and must be kept at pH 13
to prevent its acid-catalyzed decomposition.

After the 30 minute incu-

bation period, 100 pl of the appropriate borohydride solution was added
to the flasks to achieve a final borohydride concentration of either 1
mM or 2mM as desired,

The flasks were restoppered, the contents swirled

and the flasks were replaced in the shaker water bath,
Davies et al., (1962) haYe reported that borohydride is rapidly
hydrolyzed below pH 9,

Thus, at the pH of the assay mixture, the reduc-

tion of an albumin complex will occur very rapidly.

The borohydride

addition was repeated at 60, 90 and 120 minutes to ensure that a detectable level of the reduced albumin complex was attained,

Following the

last borohydride reduction step, the flask contents were exhaustively
dialyzed against water to remove unreacted labeled substrate from the

mixture.

Aliquots of

500~1

of the dialysands were removed, added to

a scintillation cocktail and the radioactivity of each sample was
determined with a Beckman LS-250 scintillation spectrometer.
Decarboxylation of Alpha Keto Acids
An investigation of the effect that albumin may have on the decarboxylation of alpha keto acids was conducted.

The assay for aceto-

acetate decarboxylase activity which measures the production of acetone
in the head space vapor by flame ionization gas
producible and extremely sensitive.

chromatograph~·

is re-

However, to measure the decarboxy-

lation of alpha keto acids, another method was needed since acetone would
not be the product.

Unfortunately, carbon dioxide cannot be measured

by flame ionization gas chromatography.

An alternative method was

tried, that of thermal conductivity gas chromatography (Bollman and
Mortimore, 1972).

Carbon dioxide can be measured by this method;

however, the sensitivity was very poor and the results were not
reproducible.
A method was developed in which radioactively labeled alpha keto
acids

(1-iLtC)-pyruvate and(1-

14
c)alpha ketoglutarate were utilized.

During the decarboxylation, labeled carbon dioxide is released.

It is

trapped in dilute sodium hydroxide and its radioactivity counted by
liquid scintillation.

The method proved useful for studying the effect

of albumin on the decarboxylation of alpha keto acids.
The decarboxylation reaction was carried out in a 25 ml Erlenmeyer
flask stoppered with a rubber septum.

In the center of the septum there

was a small hole which accommodates a long stemmed plastic collection
bucket.

The collection bucket was positioned approximately one em

50
above the reaction mixture and contained 0.3 ml of 0.1
ide.

~

sodium h·{drox-

The reaction mixture contained 10 mg of Fraction V human serum

albumin (Miles Laboratories, Elkhart, Indiana) in 2.9 ml of 50 m~
Tris buffer, pH ?.4 and 0.1 ml of the (1-

14
c)- labeled alpha keto acid.

The mixture of albumin and Tris buffer was brought to 37'C in a shaking
water bath.

The collection buckets containing the sodium hydroxide were

inserted into the flasks.

At appropriate time intervals, 100j<-1 of

labeled keto acid was added to each flask; the flask was restoppered and
replaced :tn the 37' C water bath.

After two hours of ir..cubation, the

flask was opened carefully and the collection bucket was removed.

fhe

long stem was cut from the collection bucket and the bucket was dropped
into 10 ml of a scintillation cocktail (HC-toluene-BBS-J).

~he

sdn-

ttllation vials were sealed, shaken and the radioactivitv of the sample
was counted with a Beckman LS-250 liquid scintillation counter to determine the degree of decarboxylation.
Measurement of Radioactivity
A Beckman LS-250 Liquid Scintillation Spectrometer was utllized for
all measurements of radioactivity.

The samples were counted in 20 ml

low-potassium borosilicate glass vials fitted with tin-foil-lined plastic
screw caps.

Ten ml of scintillation fluor was added to each vial.

The

fluor was prepared by dissolving 5 gm of PFO in 1 L of scintillation
grade toluene and to every 100 milliliters of this solution was added 20
ml of a solubilizing agent BBS-3 (Beckman Instruments, Fullerton,
California).

Liquid samples were introduced into the counting fluor

by the use of a Gilson Pipetman automatic pipett~r (Rainen Instrument
Co,, Brlghton, Massachusetts),

The scintillation vials were capped and
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shaken vigorously to dissolve the test material.

Dark adaptation of the

samples was complete after 30 minutes.
The efficiency of counting was determined by the method of internal
standardization.

After all the samples were counted, 100 microliters

of (C-14)-toluene standard (40,000 dpm, Beckman Instruments, Fullerton,
California) was added to the vials.

The samples were recounted.

mean value for the counting efficiency was determined to be

The

85.6% and

this mean counting efficiency was used to convert counts per minute as
recorded by the instrument to disintegrations per minute (dpm).

Quench-

ing was not a problem in the measurement of the radioactivity of the
samples.

CHAPI'ER III

RESULTS
Partial Purification of Acetoacetate Decarboxylase Activity from Bovine
Liver Homogenates
Van Stekelenburg and Koorevaar (1972) reported that rat liver homogenates exhibited acetoacetate decarboxylase activity and they postulated the existence of a mammalian enzyme.

The initial experiments in

this study centered on an attempted partial purification of acetoacetate
decarboxylase activity from bovine liver.

The purification of the bac-

terial acetoacetate decarboxylase from Clostridium acetobutylicum was
reported by Hamilton and Westheimer (1959) and some of the steps of their
procedure were used as guidelines.
Fresh beef liver, (1700 grams) was obtained from the slaughter house
(Lincoln Meat Company, Chicago, Illinois), packed in ice for transport
a~d

homogenized without undue delay at the laboratory in 2 liters of cold

acetone.

All steps in the preparation of an acetone powder were carried

out in the cold room at 4'C.

The homogenate was mixed for 1 hour and
The residue was defatted b:,· resuspend-

filtered with a Buchner funnel.

ing it in 2 liters of cold chloroform and mixing it for 1 hour.
ture was filtered as before.

The mix-

The residue was resuspended in 2 liters of

cold acetone, stirred for 1 hour, filtered and allowed to air dry.
weight of dried acetone powder was 400 grams.

The

The acetone powder was

extracted with 2 liters of 50

m~

stirring for 4 hours at 4'C.

The solid material was then removed by

phosphate buffer, pH 5.9 with continuous

centrifugat1.on in a refrigerated centrifuge at 2400 X g for 30 mjnutes.
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The supernatant was acidified to pH 3.8 with
to stand overnight at 4'C,

2~

acetic acid

a~d
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allowed

The resultant precipitate was collected by

centrifugation at 3900 rpm (2400 X g) for 30 m:lnutes and redissolved in
200 ml of 50

~

phosphate buffer, pH 5.9.

Following the Hamilton and

Westheimer (1959) procedure, a heat-activation step at 55'C for 1 hour
was performed.

Protein denaturation occurs at this step and the mix-

ture was clarified by centrifugation as before.

The supernatant was

suhjected to various approaches of purification.

These included preci-

pitation with ammonium sulfate at numerous concentrations, ultrafiltration, molecular exclusion chromatography, cation and anion chromatography, isoelectric focusing and isotachophoresis.

Only ultrafiltration

and isoelectric focusing techniques were useful in the characterization
of the acetoacetate decarboxylase activity.

Ultrafiltration of the heat-

activated material was performed with an Amicon Ultrafiltration Cell,
Model 52 (Amicon Corporation, Lexington, Mass.) fitted with an XM-50
Diaflo Ultrafiltration Membrane (Amicon Corporatlon, Lexington, V!ass.)
which has a molecular weight cutoff of 50,000,

Ultrafiltration was

carried out with continuous stirring under a nitrogen pressure of 60 lbs
per square inch in the cold room at 4'C,

Assay of the retentate and the

ultrafiltrate showed that the bulk of the acetoacetate decarboxylase
activity was found in the ultrafiltrate.

Although ultrafiltration mem-

branes do not yield quantitative molecula:.-

~·:eight

fractionation,· it

appears that the active material has a molecular weight range less than

50,000,

The active filtrate was ultrafiltered as before with a Diaflo

PM-30 membrane which has a molecular weight cutoff of 30,000.

Assa~r

of

the retentate and filtrate showed that the bulk of the activity was
associated with the PM-30 ultrafiltrate although the spec:lfic activity

of the PM-JO retentate was considerable.

Table 4 lists the acetoacetate

decarboxylase activities associated with the fractions obtained from
ultrafiltration of the heat-activated bovine liver extract.
The retentate and filtrate from ultrafiltration with the FH-JO
membrane were pooled and twenty mg of proteln from the mixture was subjected to isoelectric focusing in the pH range of J, 5-10 for

500 volts.

L~8

hours at

Fractions of 2.5 ml each were collected from the column and

the protein content of the effluent was monitored at 280

~m.

Figure 6

depicts the UV absorption curve and the superimposed pH curve.

The con-

tents of tubes 1 through 10 comprise the anode solution and were discarded.

The contents of tubes 11 through 17 were pooled and l:rophilized

(Fraction I).

The contents of tubes 18 through 45 were pooled and lyo-

philized (Fraction II).

Fraction I and II were reconstituted in one ml

of 50 mM Tris buffer, pH 7.4 and aliquots were assayed for acetoacetate
decarboxylase activity,

Fraction II was found to produce acetone at the

same rate as the reagent blank, 2 X 10

-4

mole min

found to produce acetone at the rate of 4 X 10

-4

-1

•

Fraction I was

mole min

-1

•

The active

acetoacetate decarboxylase component of bovine liver extracts has a molecular weight less than JO,OOO and a pi of approximately 4.
In 1976, Koorevaar and van Stekelenburg presented further evidence
that mammalian acetoacetate decarboxylase activity is associated with the
albumin fraction of human serum.

As a result of this report, further

attempts of characterizatlon of the enzymic activity from bovine liver
were discontinued and attention was soon focused on the decarboxylase
activity associated with human serum albumin.
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Table 4
Acetoacetate Decarboxylase Activities of Fractions Obtained from
Ultrafiltration of Heat-Activated Bovine Liver Extract

Fraction
Protein Collected After

Acetoacetate
Decarboxylase
Activity
(Units)

Total
Activity
Units x gms
of protein

0.86

437

Acidification with Acetic Acid

Heat Activated Material

1.2

Retentate from

0.??

55

XM-50 ( > 50,000)

Ultrafiltrate from

4.1

259

2.1

43

4.1

252

XM-50 ( < 50,000)

Retentate from
PM-30 ( > 30,000)

Ultrafiltrate from
PM-30 ( < 30,000)

Figure 6. Isoelectric resolution of the less than 50,000 molecular
weight fraction from an ultrafiltrate of bovine liver homogenate.
Electrophoretic resolution of a 21 mg pool of active protein
of molecular weight less than 50,000 in a LKB 8100 electrofocusing
column. The pH gradient extends from 3.5 to 10.0. Each tube contains
2.5 ml. Tubes 1 throue;h 10 contain anode electrode solution; Fraction
I (tubes 11 through 17) exhibited acetoacetate decarbox.rlase activity;
Fraction II (tubes 18 through 45) contained no detectable acetoacetate
decarboxylase activity. Resolved peak of Fraction I has a pi of 4.
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Effects of Experimentally-Induced Diabetes Mellitus and of Starvation
on the Acetoacetate Decarboxylase Activity of Rat Flasma
In the first paper by Van Stekelenburg and Koorevaar (1972), it is
inferred that an enzyme is responsible for the decartoxylation of acetoacetate in mammalian systems.

To ascertain whether the acetoacetate de-

cartoxylase activity is inducible during the metabolic stress of diabetes,
a group of rats were made diabetic to increase their plasma concer.tration of oxybutyrates.

Assay for acetoacetate decarboxylase activity dur-

ing the diabetic state will determine whether the activity is jnducible
or constitutive.
Adult male rats (Locke-Erickson, Maywood, Illinois) were used in
this study and were kept in individual cages.

They were acclimated jn

the animal quarters for four days before use.

Laboratory chow and water

were provided ad libitum.
weight of 344 grams.
each.

At time of use, the rats had a mean body

Six rats were divided into two groups of three rats

One group served as control animals.

Streptozotocin (Upjohn Com-

pany, Kalamazoo, Michigan) was used to induce diabetes mellitus in the
second group of rats.
Solutions of streptozotocin are very unstable and must be injected
within ten minutes of their preparation.
zotocin used to induce diabetes was

The concentration of strepto-

65 mg/kg body

w~ight.

The animals

were weighed and the appropriate amount of drug to be administered was
weighed in small test tubes and kept at 4'C until the animals were
prepared for the injection.
To facilitate handling, the animals were placed under a light anesthesia with an intraperitoneal injection of sodium pentobarbital of a
concentration of

32.5 mg/kg of body weight. Blood samples were collected
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from the animals to obtain initial levels for acetoacetate decarboxylase
activity and for plasma glucose.

The animals were weighed and blood

samples were taken between 9 a.m. and 10 a.m. on the day of the testing.
Once the blood samples were obtained, the appropriate test tube containing the streptozotocin was diluted with 0.2 ml of 50
pH

m~

citrate buffer,

4.5 and the solution was injected intraperltoneally. The control

animals were handled in the same manner except that a placebo of 0.2 ml
of the citrate buffer was used in place of the streptozotocin.
After 24 hours, blood samples were collected from all the animals
and the appropriate groups were reinjected wi.th streptozotocin or the
placebo,

Body weights and blood samples were obtained again after 72,

120 and 144 hours.

Glucose and acetoacetate decarboxylase levels were

determined as previously descrlbed for all animals.
In Table

5 are presented the changes in body weiehts, plasma f.lucose

concentration and plasma acetoacetate decarboxylase activity durjng the
experimental regime.

Over the six day experimental period, the control

animals maintained their weight.

The streptozotocin-treated animals lost

weight but the weight loss was not stri.king.

Over the same time period,

the glucose levels of the control animals varied little.

The glucose

levels of the streptozotocin-treated animals increased markedlY, a mean
i.ncrease of 249% was noted after six days.

The acetoacetate decarboxy-

lase activity of the plasma of both the control and the streptozotocintreated animals remained fairly constant,

There was no evidence of a

definite increase if1 the acetoacetate decarboxylase activity of the diabetic animals.

Thus, the onset of the diabetic state did not induce

acetoacetate decarboxylase activity,
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Table 5
Changes in Body Weight, Plasma Glucose Concentration and Plasma
Acetoacetate

Decarbo~Jlase

Activity of Control and Streptozotocin-

treated Rats over a Period of Six Days and for the Streptozotocintreated Animals, After a Subsequent Four Day Fast.
0 Hours

Wei~ht

Glucose
{me;Ldl}

{eJ

Acetoacetate
Decarboxylase
(Units)

Control #1

320

124

O.J?

#2

31/J.

116

0.27

#3

334

122

0.23

Test #1

333

122

O.JO

#2

349

141

0.28

#3

414

128

0,21)

24 Hours
Control #1

314

136

0,3h

#2

310

134

0.34

#3

325

127

0.34

Test #1

328

208

0.2)

#2

339

311

0.21

#J

J98

J69

0,20
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Table 5 (Continued)
72 Hours
Glucose
(meldl}

Weight (g~

Acetoacetate
Decarboxylase

(Uni~-

Control #1

321

114

0.25

#2

317

124

0.2J

#3

327

117

0.25

Test #1

313

388

0.2J

#2

J35

383

0.25

#J

383

408

0.27

120 Hours
Control #1

322

158

O.JO

#2

325

133

O,li-0

#3

340

124

0.4J

Test #1

318

428

0.31

#2

331

#3

395

548

0.32

144 Hours
Control #1

J22

134

0.58

i/2

318

117

O.J2

#3

334

123

0.)2

Test #1

308

422

0.28

#2

334

422

0.31

#3

403

513

0.29
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Table

5 (Continued)

After a subsequent 4 day fast

Weight (g2

Glucose
(mgLdl2

Acetoacetate
Decarboxylase
~Units2

Test #1

258

118

0.20

#2

280

144

0.22

#3

333

152

0.32
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To place more stress upon the diabetic animals, their laboratory
chow was removed after 144 hours.

The diabetic animals were starved for

four days and blood samples were collected once again so that the acetoacetate decarboxylase activity could be assessed further.

However, even

starvation secondary to the diabetes did not induce an increase in the
level of acetoacetate decarboxylase activity.
The Effect of Acylating Agents on the Acetoacetate Decarbox}'lase Activity
of Human Serum Albumin
The mechanism of action for the decarboxylation of acetoacetate by
the bacterial enzyme acetoacetate decarboxylase, occurs through a Schiff
base intermediate which forms between the carbonyl group of acetoacetate
and the epsilon amino terminal of a lysine residue in the active sHe.
The formation of a Schiff base in the mechanism for decarboxvlation
requires the presence of a free amino group.

The primary source of free

amino groups in human serum albumin would be the epsilon amino terminals
of lysine residues.

Jonas and Weber (1970) found that the epsilon amino

groups of lysine in the bovine serum albumin molecule can be blocked after
acylating the site with a dicarboxylic anhydride such as succinic and
citraconic anhydride (2-methylmaleic anhydride).

Maximum reaction with

the amino groups of bovine serum albumin and succinic anh-rdrjde occur
at a molar ratio of 15:1, anhydride to amino groups and a ?0-8o% modification of bovine serum albumin with citraconic anhydride occurs at a
molar ratio of 1:1, anhydr:l.de to amino groups (Jonas and Weber, 1970).
On the basis of these consideration, it was decided to study the
effect of acylation agents on the acetoacetate decarboxylase activity of
human serum albumin to obtain further evidence for the formation of a
Schiff base intermediate in the mechanism of action.
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The free amino group content of Fraction V human serum albumin was
determined by the method of Matthews et. al., (19(,4).

A 1% solution of

Fraction V human serum albumin (Miles Laboratories, Elkhart, Indiana),
was found to have a free amino group content of 7.6

~·

The molar

ratios of succinic and citraconic anhydride used in the acylations of
albumin were based on this value.

The acylations

were carried out as

described in the chapter on Materials and Methods.

The succinated albu-

min solutions were lyophilized and reconstituted with 2.0 ml of 50 mM
Tris buffer, pH 7.4.
ty,

200~1

For the assay of acetoacetate decarboxylase activi-

of the reconstituted succinated album]n solution ard 0.1 ml of

0.45 ,!:'! lithium acetoacetate solution were placed in the test reaction
flasks.

The control reaction flasks contained

200~1

of reconstituted

unacylated human serum albumin and 0.1 ml of 0.45!! lithium acetoacetate
solution.

Table 6 shows the inhibitory effect on the acetoacetate decar-

boxylase activity of the human serum albumin of the acylating agent
succinic anhydride in the range of molar ratios of 0.025:1 to 0.25:1, anhydride to free amino group.

Figure 7 presents the dose dependent res-

ponse of inhibition observed for the acetoacetate decarboxylase activity
of succinated albumin.
Minimal acylation of human serum albumin by succinate will inhibit
the acetoacetate decarboxylase activity.

This is evident by the fact

that the free amino group content of succinated albumin rema1ns fairly
constant at low levels of acylation.

It appears that very few s1tes on

the albumin molecule are involved in the reaction with acetoacetate.
The second acylating agent, citraconic anhydride, has a dist1nct
advantage over succinic anhydride in that the ligand can be readily
hydrolyzed from albumin (Jonas and Weber, 1970)~

Human serum albumin
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Table 6
Acetoacetate Decarboxylase Activity of Succinyl Human Serum Albumin
Succinic Anhydride:
<><.NH Group

2

Molar Ratio

Number
of Determinations

Acetoacetate*
Decarboxylase
(Units)

Per cent*
of Control
Activity

Free Amino
Croup Content
pgjmg Protein

Control

5

1. 09 .! 0.11

0.025:1

4

0.94 + 0.15

79-9.:!: 10.5

0.05:1

5

0.64 + 0.13

57. 5 .!

0.10:1

5

0.40.! 0.17

35.4.! 5.0

6.15 .!

0.15:1

5

0.26.! 0,04

24.2 + 2.8

5.88.:!: 0.23

0.20:1

5

0.21,!0.03

18.7.:!: 2.0

5. 97 .! o. 29

0.25:1

5

0.17.:!: 0.02

14.8 + 1.7

5.81_:!:0.13

*

Mean + Standard Error of the Mean

0.73.! 0.29

~.9

f) • 52

.! 0. 24

6.68 + 0.16

o. 28

Figure 7. Dose dependent response of inhibition observed for
the acetoacetate decarboxylase activity of human serum albumin
after acylation with succinic anhydride.
1% solutions of Fraction V human serum albumin were reacted
with succinic anhydride. The reaction was carried out at room temperature with continuous stirring and the pH maintained at 7.0 by the
dropwise addition of 1 ~ NaOH. The reaction was deemed complete when
no further addition of NaOH was necessary to keep the solution at pH
7.0. Unreacted succinate was removed by dialysis agai~st water. The
acetoacetate decarboxylase activity was determined as previously described. The sample reaction mixture contained 2.7 ml of 50 mN Tris
buffer, pH 7.4, 0.1 ml of 0.45 M lithium acetoacetate and 0.2-ml of the
succinated albumin complex. For the blank reaction mixture, 0.2 ml of
deionized water was substituted for the test sample.
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can be acylated with citraconic anhydride and the acetoacetate decarboxylase activity of the complex can be determined.

After the determln-

ation of the catalytic activity, the citraconyl group can be removed and
the albumin reassayed for acetoacetate decarboxylase activity.

Subse-

quent recovery of acetoacetate decarboxylase activity upon reassay would
demonstrate the essential need of a free epsilon amino group for catalytic
activity of albumin.
At a molar ratio of 1:1 citraconic anhydride to free amino content,
the epsilon amino terminals of albumin are maximally acylated.

At molar

ratios between 0.25:1 and 1:1, the acetoacetate decarboxylase activity
of human serum albumin was maximally inhibited.

Ninhydrin assay of the

citraconyl albumin samples demonstrated marked decreases in the free amino
content between molar ratios of 0.25:1 and 1:1.

Two molar ratios of

citraconic anhydride to free amino group were used in the acylation, 0.10:1
and 0.25:1.

These concentrations were chosen because at a molar ratio of

0.25:1 the acetoacetate decarboxylase activity is maximally inhibited
while at a molar ratio of 0.10:1 the activity is inhibited by

60%.

Un-

reacted citraconate was removed by passage of the acylated albumin
through a Sephadex G-25 column.

After assaying the acetoacetate decar-

boxylase activity of the citraconyl albumin samples, the ligand was removed by hydrolysis.

Hydrolysis was per£ormed by lowering the pH of the

citraconyl albumin samples to 2.5 and stirring the resultant solution
continuously at 4'C for 18 hours.

The citraconate released was removed

by passage of the samples through a Sephadex G-25 column.

The acetoace-

tate decarboxylase assays for this set of experiments wer(' carrj eel out in
the same manner as were those with succinated albumin.

Table 7 lists

the acetoacetate decarboxylase activity of human serum albumin after
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Table 8 presents the acetoacetate

acylation with citraconic anhydride.

decarboxylase activity of human serum albumin after the removal of
citraconyl groups from the citraconyl albumin complex.
The acetoacetate decarboxylase act:i.vi ty of human serum albumin is
markedly decreased by its acylation with citraconic anhydride.

Inhibi-

tion of the decarboxylase activity by the acylating agent further demonstrates the essentiality of the free amino groups for the catalytic activity associated with albumin.

The inhibition of acetoacetate decarboxy-

lase activity resulting from the attachment of the citraconyl group to
the epsilon amino groups of albumin is reversible as shown by the
recovery of activity from the hydrolyzed citraconyl-album:in complex.
The acetoacetate decarboxylase activities of the albumin samples
following removal of the citraconyl group are greater than those observed
for the citraconyl albumin complex.

This qualitative difference was also

observed for the activities of the control albumin samples subjected to
the same conditions of hydrolysis.

These phenomena may be explained in

terms of the microheterogeneity of albumin.

During the hydrolysis of the

citraconyl albumin complex the pH of the solution is lowered to
Below pH 4

2.5.

aibumin undergoes a transition to another molecular species

called the expanded form (Foster et. al., 1965).

In the expanded form,

groups which were folded into the interior of the albumin molecule become
available at the hydrophilic surface.

Jonas and Heber (1970) estimate

that after the acid expansion of bovine serum albumin, 20% of the buried
lysire residues become uncovered.

The acid expansion of albumin may

accour.t then for the increased acetoacetate decarboxylase activity observed
after the acid hydrolysis of the citraconyl albumin complex.

However,

of more import, was the finding that catalytic activity was recovered
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Table 7
Acetoacetate Decarboxylase Activity of Citraconyl Human Serum Albumin
Citraconic
Anhydride:
<><. NH Group

2

Molar Ratio

Number
of Determinations

Acetoacetate*
Decarboxylase
_(Units)

Per Cent*
of Control
Activitv

Free Amino
Group Content
pg/mg Protein

Control

3

0.93.! 0.14

0.10:1

3

0.36.! 0.08

37.6 + 4.1

6.48.! 0.4.5

0.2.5:1

3

0.11 .! 0. OJ

11.7_!1.8

.5.33.! o.63

6. 6.5 .! 0, 64

*Mean + Standard Error of the Mean

Table 8
Acetoacetate Decarboxylase Activity of Human Serum Albumin After
Removal of Citraconate from Citraconyl Albumin Complex
Citraconic
Anhydride:
o<.. NH Group

2

Molar Ratio

Number
of Determinations

Acetoacetate*
Decarboxylase
(Units)

Per Cent*
of Control
Activity

Free Amino*
Group Content
Eefmg Protein

Control

3

1.21 .! 0.1.5

0.10:1

3

1.11 .! 0.1.5

92.0.! 0.9

5.55.! 0.57

0.25:1

3

0.83_!0.14

67.6.! 2.8

5.55.! 0.32

t_) .11

* Mean + Standard Error of the Mean

.! o• .52
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from the removal of the acylating agent providing further support for a
role of the free epsilon amino group of lysine in acetoacetate decarboxylation.
The Effect of Beta Diketones on the Acetoacetate Decarboxylase Activity
of Human Serum Albumin.
To obtain further evidence of acetoacetate decarboxylase activity
associated with Fraction V human serum albumin characterization of the
activity is necessarJ.

Beta diketones are powerful competitive inhibi-

tors of the bacterial enzyme that interfere with the formation of the
Schiff base intermediate.

To demonstrate a similar relationship in the

mechanistic scheme, the effect of two beta diketones, acetopyruvate and
acetylacetone, on the acetoacetate decarboxylase activity of human serum
albumin was performed.
ranged from 0.10

~to

action flask was 10 mg.

The concentration of acetopyruvate emplo::ed
2.0

~and

the albumin concentration in each re-

Table 9 shows the per cent inhibition of aceto-

acetate decarboxylase activity of the albumin at various concentrations
of acetopyruvate.

Figure 8 demonstrates the relationship between the

concentration of acetopyruvate and the extent of inhibition by the diketone.
The effect of acetylacetone was performed in the
range of 10 mM-80 mM.

As with acetopyruvate, each reaction mixture con-

tained 10 mg of Fraction V human serum albumin.
cent

inhibitio~

conce~tration

Table 10 shows the per

of acetoacetate decarboxylase activity of the albumin at

various concentrations of acetylacetone.

Figure 9 demonstrates the rela-

tionship between the concentration of acetylacetone and the extent of
inhibition caused by the diketone.
Both acetopyruvate and acetylacetone have marked inhibitory effects
on the acetoacetate decarboxylase activity of Fraction V human serum
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Table 9
Effect of Acetopyruvate Upon the Acetoacetate Decarboxylase Activity
of Fraction V Human Serum Albumin
Acetoacetate
Decarboxylase
Activity
(Units)

Per Cent *
Inhibition

Concentration of
Acetopyruvate

Number of
Determinations

Control

5

0.98 .! 0.03

0.10 m!1

5

0.86

0.01

12.2.! 1.7

0.25 m!:!

5

0.82.! 0.01

15.9.! 1.9

0.,50 m!:!

5

0.72.! 0.01

26.5.! 0.9

1.00 mM

5

0.66.! 0.02

32.2.! 1.7

2.00 ml1

5

0.55.! 0.03

4J.5.! 2.6

*

.±

Mean .! Standard Error of the Mean

Figure 8. The effect of acetopyruvate on the acetoacetate decarboxylase activity of Fraction V human serum albumin.
The acetoacetate decarboxylase activity was determined as previously described. The sample reaction mixture contained 2.h ml of
50~~ Tris buffer, pH ?.4, 0.1 ml of a stock acetopyruvate solution
necessary to bring its concentration in the reaction mixture to the
predetermined level, 0.1 ml of 0.45 ~lithium acetoacetate and 10 mg
of Fraction V human serum albumin in 0.2 ml of deionized water. For
the blank reaction mixture 0.2 ml of deionized water was substituted
for the test sample.
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Table 10
The Effect of Acetylacetone on the Acetoacetate Decarboxylase Activity
of Fraction V Human Serum Albumin

Concentration of
Acetylacetone

Number of
Determinations

Acetoacetate
Decarboxylase
Activity
(Units)

Per Cent *
Inhibition

Control

10

10 mM

4

0.96..!

o.oo

3.5..! O.J

~

4

0.90..! 0.01

9.1..! 1.1

40 mM

4

0.50..! o.oo

49.0..! O.J

60 mM

4

0.46..!

0.05

54.0.:!: 6.2

80 mM

4

0.22..! 0.02

78.2.:!: 2.6

20

*

0.99 _! O.OJ

Mean ..! Standard Error of the Mean

Figure 9. The effect of acetylacetone on the acetoacetate decarbo~rlase activity of Fraction V human serum albumin,
The acetoacetate decarboxylase activity was determined as previously described, The sample reaction mixture contained 2.( ml
of 50 mM Tris buffer, pH ?.4, 0.1 ml of a stock acetylacetone
solution necessary to bring its concentration in the reaction mixture
to the predetermined level, 0.1 ml of 0.45 M lithium acetoacetate and
and 10 mg of Fraction V human serum albumin-in 0.2 rnl of deionized
water. For the blank reaction mixture 0.2 ml of deionized water Has
substituted for the test sample.
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albumin.

This observation is not unexpected if the mechanism of decar-

boxylase action by albumin occurs through a Schiff base intermediate.
The beta diketone will react with the epsilon amino group of lysine
rendering it inaccessible to the substrate acetoacetate.

The hicr,her the

concentration of the diketone the more effective its competition for the
active lysine residue and therefore, the inhibition is greater.
The Effect of Borohydride on the Acetoacetate Decarboxylase ActivHv of
Human Serum Albumin
Sodium borohydride is a known reductant of enzymes whose mechanism
occurs through a Schiff base intermediate (Fischer, et. al., 1958, Grazi
et. al., 1962, Horecker et. al., 1961, Dempsey et. al, 1962 and Fridovich
and lrJestheimer 1962).

To gain information on the mode of action for the

acetoacetate decarboxylase activity associated with human serum albumin,
a borohydride reduction was performed.
Porohydride will reduce not only Schiff base intermediates but also
the substrate acetoacetate and the product produced in the decarboxylation reaction, acetone,

Thus, the assay for acetoacetate decarboxylase

by head space analysis cannot be used in this experiment beca,Jse of the
inacility to measure precisely the acetone release.

To investi8ate the

borohydride reduction of an albumin-acetoacetate complex the assay
developed for trapping Schiff base intermediates (Fridovich and :festheimer
19~2)

was modified for use in this study.

Fractlon V human serum albumin with (Jin 2.9 ml of 50

zn.t!

Tris buffer, pH ?.4.

Incubation of 10 mg of

14
C) acetoacetate was carried out
If the mechanism of action for

the decarboxylation of acetoacetate occurs through a Schlff rase ir.termediate, a ketimine will be formed which is redud ble by borohydride.
Reduction of the ketimine intermediate results in the formation of a
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The bacterial enzyme has a low K and,
m
therefore, when borohydride is added to the reaction mixture, there is a

radiochemically labeled complex.

considerable amount of reduction occurring at the enzyme-substrate level.
This is not the case for albumin because the acetoacetate decarboxylase
activity associated with the molecule has a high Km, approximately 0.1
(Koorevaar and Van Stekelenburg, 1976).

N

The addition of borohydride to

the albumin-reaction mixture results in a much lower level of reduction
at the albumin complex site.

To compensate for the high Km associated

with the albumin fraction, the reduction was performed every JO minutes
for 2 hours.
The use of 1

Various concentrations of sodium borohydride were employed.
~and

2

~

sodium borohydride were found to be effective

in the trapping of a radiochemically-labeled albumin complex (Table 11).
For each borohydride reduction of the solution containing albumin
and (J-

14

c) acetoacetate, there is a significant incorporation of label

in the albumin molecule.

The radiochemically-labeled albumin complex is

stable; its radioactivity is not lost after exhaustive dialysis.

The

trapping of the radiochemically-labeled albumin offers evidence that the
mechanism of action utilized by Fraction V human serum albumin occurs
through a Schiff base intermediate.
The Effect of Acetopyruvate on the Borohydride Reduction of the Human
14
Serum Albumin-(J- C) Acetoacetate Complex
Acetopyruvate acts as a competitive inhibitor of the bacterial enzyme acetoacetate decarboxylase; the carbonyl group adjacent to the methyl
group forms a Schiff base with the epsilon amino group of lysine in the
active site.

The resultant ketimine complex forms a non-productjve irter-

mediate which has been isolated (Tagaki et. al., 1968).

The non-produc-

tive binding of acetopyruvate to the enzyme interferes with the
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Table 11
The Trapping of a Radiochemically-Labeled Albumin-Acetoacetate Complex
by Borohydride Reduction
Experiment 1
Sample

DPM/mg Protein

Control

515

Per Cent Increase

1616

214

1250

143

Experiment 2 .
Control

856
1443
1341

57

Experiment 3
Control

1383
2010

45

Experiment 4
Control

450
987

119

1061

13()

Ex.:.eeriment 5
Control

519

949

8)

1293

149

r
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Table 11 (Continued)
Experiment 6
Sample

DPM/mg Protein

Control

768

1

Jn!i

BH-

1

Jn!i

BH-

2

Jn!i

BH-

2

Jn!i

BH-

4
4
4
4

Per Cent Increase

1000

JO

975

27

1072

lJ.O

982

28
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productive binding of acetoacetate to the active site.
It has been shown in this study that acetopyruvate will inhibit the
acetoacetate decarboxylase activity of Fraction V human serum

alb~min.

Experiments on the borohydride reduction of the albumin- ( J- ill-C) acetoacetate complex have given evidence that the mechanism of action of albumin in the decarboxylation of acetoacetate occurs through a Schiff
base intermediate.

To gain further support for the mechar:isrn of action,
14
the borohydride reduction of the albumin-(3- c) acetoacetate complex

was conducted in the presence of acetopyruvate.

If a Schiff base inter-

mediate is formed between the albumin and acetoacetate, acetopyruvate
will interfere with the binding at the active site.

The competition be-

tween acetopyruvate and acetoacetate for the site will become evident by
a decrease in the radioactivity of the borohydride-reduced albumin-acetoacetate complex.

Preliminary studies showed that 6

~

acetopyruvate in-

hibits the acetoacetate decarboxylase activity of human serum albumin by
approximately
study,

80%

and this concentration of the inhibitor was used in this

The borohydride reduction of the albumin-(3-

14
c) acetoacetate

complex, the trapping of the radiochemically labeled albumin complex and
the measurement of radioactivity were performed as previously described.
Table 12 presents the extent of incorporation of the label in the albuminacetoacetate complex after performing the borohydride reduction in the
and in the absence of acetopyruvate. Acetopyruvate when incu14
.
bated with (3- C) acetoacetate and Fraction V human serum albumin was
prese~ce

found to inhibit the formation of a labeled acetoacetate-albumin complex.
In tr~ee of the experiments (2,3,4), the per cent of label incorporated
into the complex was decreased by 55 + 1. 0% (S. E. M. ) •
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Table 12
The Effect of Acetopyruvate Upon the Borohydride
Reduction of Albumin (3-

14c) Acetoacetate

Experiment 1

14c) Acetoacetate+ Human Serum Albumin
14
(3- c) Acetoacetate +Human Serum Albumin
(3-

+ 6 roN Acetopyruvate
(3-

Incorporation
of Label
DPM/mg
Percent of
Protein ----·-·
Control
--

1504

1327

14c) Acetoacetate +Human Serum Albumin
+ 1 m!1 BH 4

88

2h47

11

(3- ~c) Acetoacetate + Human Serum Albumin
+ 6 ~ Acetopyruvate + 1 mM BH
4

8l!-1

Experiment 2
14
c)
1
(3- L"c)
(3-

Acetoacetate +Human Serum Albumin

1630

Acetoacetate + Human Serum Albumin
+ 6 roM Acetopyruvate

755

Acetoacetate +Human Serum Albumin
+ 1 mM BH -

2591

Acetoacetate +Human Serum Albumin
+ 6 ~ Acetopyruvate + 1 m~ BH -

771

ExJ>eriment 3
11
(3- "c) Acetoacetate + Human Serum Albumin

418

14c) Acetoacetate + Human Serum Albumin
+ 6 mM Acetopyruvate

180

(3-

14

c)

4

(J-

14
c)

4

(3(3(3-

14

c)

Acetoacetate +Human Serum Albumin
+ 1 rnM BH4

14c) Acetoacetate + Human Serum Albumin
+ 6 ~ Acetopyruvate + 1 m!1 BH
4

46

30

43

1196
388

32

80

Table 12 (Continued)

Experiment 4
14
c)
14
(3- c)
(3-

(3(3-

14
c)
14
c)

Incorporation
of Label
DPM/mg
Percent of
Protein
Control

Acetoacetate +Human Serum Albumin

430

Acetoacetate +Human Serum Albumin
+ h mM Acetopyruvate

200

Acetoacetate + Human Serum Albumin
+ 1 m!1 BH 4

1061

Acetoacetate +Human Serum Albumin
+ 6 m!1 Acetopyruvate + 1 mM BH 4

404

47

38
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For each borohydride reduction of the solution containing albumin
and (3-

14
c) acetoacetate, there was, as expected, an increased incor-

poration of the label into the albumin complex in the absence of acetopyruvate.

In all four experiments, when the borohydride reduction was

carried out in the presence of 6

~

of incorporation of label occurred.

acetopyruvate significant inhibition
The incorporation was decreased by

66 _! Z'/o (S.E.M. ).
Acetopyruvate interferes with the borohydride reduction of the albumin-(3-14c) acetoacetate complex and acts in a manner similar to that observed for the bacterial enzyme.

It is postulated that acetopyruvate

reacts with albumin forming a ketimine with an epsilon amino group of lysine.

The acetopyruvate competes with acetoacetate for the active ly-

sine residues on the albumin molecule and the competition results in
fewer labeled ketimine intermediates available for reduction by borohydride.

The observed data give supportive evidence that the mechanism of

action for the decarboxylation of acetoacetate occurs through a Schiff
base intermediate.
The Effect of Human Serum Albumin on the Decarboxylation of Alpha
Ketoglutarate and Pyruvate
The bacterial enzyme acetoacetate decarboxylase is very specific
for acetoacetate having no action on the decarboxylation of alpha or
other beta keto acids.

To investigate the effect of Fraction V human

serum albumin on other substrates, two alpha keto acids were chosen,
~-ketoglutarate

and pyruvate.

To measure the decarboxylation rate, the

liberation of carbon dioxide was measured radiochemically.
(1-

14

c) sodium pyruvate and fifty

Fifty ~Ci of

.rcJ.. of (1- 14c) <~{-ketoglutarate

England Nuclear, Boston, Mass.) were brought to a

(r;ew

concentration of
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0.4~

with the corresponding unlabeled alpha keto acid.

Each reaction

mixture contained 10 mg of the albumin in 2.9 ml of 50 m,!::! Tris buffer,
pH ?.ll- and 100f""l (5rCi) of the labeled keto acid solution.

'The decar-

boxylation reaction was carried o.ut at 37'C for two hours.

The labeled

carbon dioxide was trapped in the sodium hydroxide solution

co~tained

in a plastic collection bucket.

The extent of decarboxylation was deter-

mined by measuring the trapped labeled carbon dioxide in the sodium hydroxide solution by liquid scintillation.
2.9 ml of 50 m,!::! Tris buffer, pH ?.4 and

Blank solutions containir.g

10~~1

monitor the nonenzymatic decarboxylation.

of substrate were run to

Table 13 shows the effect of

human serum albumin (HSA) on the decarboxylation of alpha ketoGlutarate
and pyruvate in terms of the radioactivity of the trapped labeled carbon dioxide.

The counts obtained from the decarboxylation of

~-ketoglu

tarate and pyruvate in the presence of Fraction V human serum albumin
were lower than those for the corresponding blank solutions.
indicate

The data

that albumin will not stimulate the decarboxylation of

o(-ketoglutarate or pyruvate.

The decarboxylation of the alpha keto

acids in solution is actually decreased in some unknown manner by the
albumin.
The Effect of Bound Fatty Acids on the Acetoacetate Decarboxylase
Activity of Human Serum Albumin
Unlike other plasma proteins albumin has numerous functions; it is
the principal material responsible for the oncotic pressure of the blood
and it transports fatty acids and bilirubin.

Albumin has other less

defined functions such as the transport vehicle for tryptophan, various
hormones and drugs; it also serves as a source of amino acids in the
peripheral tissues.

Table 13
The Effect of Human Serum Albumin (HSA) on the Decarboxylation
of Alpha Ketoglutarate and Pyruvate
Alpha ketoglutarate

Experiment No.

Sample
Reagent Blank (2)

1.

Radioactivity
of the Trapped
DPM

co2

1922
1fJt

HSA (5)
Reagent Blank (2)

2.

1088 ~ 23 (S.E.M.)
3172

2553
HSA (3)

1106 ~ 33 (S.E.M.)

Pyruvate
Experiment No.
1.

Reagent Blank

l~598

4472
HSA (4)
2.

Reagent Blank

3027 ~ 38 (S.E.M.)
_5/-1-51

5333
HSA

(3)

3037 ~ 34 (S.E.M.)

The number of determinations is shown in the parenthesis
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Long chain fatty acids are highly insoluble at pH 7.4 and their
presence in plasma is largely due to the binding properties of albumin.
Ashbrook (1975) reported that 99.9% of the fatty acids in the circulation are bound to albumin.

One or two fatty acid residues are bound per

molecule of albumin by the insertion of the aliphatic chains

i~to

the

hydrophobic clefts of the molecule (Peters 1975).
To investigate the effect of bound fatty acids on the acetoacetate
decarboxylase activity of albumin, defatted Fraction V human serum albumin was assayed for its acetoacetate decarboxylase activity.

The defat-

ted Fraction V albumin (Miles Laboratories, Elkhart, Indiar:a, Code No,

82-323, Lot No. 13) was reported to be 98% pure as determined b:; cellulose acetate electrophoresis in 0.75

~barbital

buffer, pH 8.6 and to

contain less than 0.1 mole of fatty acid per mole of albumin.

Ten mg

samples of the defatted Fraction V human serum albumin were assayed for
acetoacetate decarboxylase activity, as were 10 mg samples of Fraction V
human serum albumin.

Table 14 shows the percent increase in the aceto-

acetate decarboxylase activity of defatted Fraction V human serum albumin
over that observed for Fraction V human serum albumin.

This is not unex-

pected since the bound fatty acids most likely will interfere sterically
with some of the epsilon amino groups of lysine residues.

Cnce the fatty

acids are removed from the hydrophobic clefts of albumin, more lysine
residues are available for reaction with acetoacetate and hence, the
acetoacetate decarboxylase activity of defatted albumin is greater.
The Effect of Guanidine-HCl on the Acetoacetate Decarboxylase Activitv of
Human Serum Albumin
Guanidine-HC1 is known to cause disruptions iP the secondary
structure of proteins.

Wallevik (1973) has showl'1 by optical rotation

Table 14
Acetoacetate Decarboxylase Activity of Fraction V Human Serum
Albumin and Defatted Fraction V Human Serum Albumin

Test Material
Fraction V Human

Number
of Determinations

Acetoacetate*
Decarboxylase
Activity
(Units)

5

0.95 2: 0.0

5

1. 30

Serum Albumin
Defatted Fraction V
Serum Albumin

* Mean + Standard Error of the Mean

.!

0.1

rer Cent
Increase
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studies that minor changes occur in the secondary structure of human
serum albumin at concentrations of less than 1 M,
Ten mg samples of human serum albumin were assayed in the presence
of guanidine-H01 to study the effect that minor disruptions in the secondary structure of the molecule have on the acetoacetate decarboxylase
activity.

The concentration of guanidine-HC1 used in the study ranged

from .50 Il'l.!1-1000 Il'l.!1·

Table 1.5 lists the mean percent of inhibition ob-

served in the acetoacetate decarboxylase activity resulting from secondary structural disruption by guanidine-HCl.

A graphical representation

of the inhibition attained in the presence of various concentrations of
guanidine-HCl is shown in Figure 10.
Very low concentrations of guanidine-HCl will cause a considerable
inhibition of the acetoacetate decarboxylase activity of human serum albumin.

Inhibition begins to level off somewhat at a guanidine-HCl con-

centration of 400 mM.

Thus, the acetoacetate decarbox:ylase activity of

albumin is extremely sensitive to minor changes in the secondary
structure of the molecule.
The Effect of Various Monovalent Anions on the Acetoacetate Decarboxylase
Activity of Human Serum Albumin
Studies of specific effects of anions on colloidal systems in
aqueous systems date back to Hofmeister (1888) who measured the effects
of various salts on the solubility of egg albumin.

Series of anions

arranged in order of ability to modify some observable function and similar in sequence to the series of anions found by Hofmeister are usually
referred to as Hofmeister or Lyotropic Series (Fridovich, 1963).

Aceto-

acetate decarboxylase of Q!_. acetobutylicum has been shown to be strikingly sensitive to inhibition by anions (Fridovich, .. 196J).

The anions react
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Table 15
The Effect of Guanidine-HCl Upon the Acetoacetate Decarboxylase
Activity of Human Serum Albumin

Concentration of
Guanidine-HCl

Number of
Determinations

Acetoacetate
Decarboxylase
Activity
(Units)

Per Cent *
Inhibition

Control

6

1.02_!0.01

50 m.M

5

0.95.! 0.02

7.3.! 2.2

100 mM

5

0.86.! 0.02

15.7.! 2.7

200 mM

5

0.74.! 0.01

27.2.! 1.3

400 mM

5

0.57.! 0.01

43.8 .! 1.4

800 mM

5

0.49.! 0.01

51.8.! 0.5

1000 mM

5

0.40 + 0.01

60.6.! 0.5

*

Mean .! Standard Error of the Mean

Figure 10. The effect of guanidine-HC1·on the acetoacetate decarboxylase activity of Fraction V human serum albumin.
The acetoacetate decarboxylase activity was determined as previously described. The sample reaction mixture contained 2.h ml of 50
~j Tris buffer, pH ?.4, 0.1 ml of a stock guanidine-HCl'solutjon necessary to bring its concentration in the reaction mixture to the predetermined level, 0.1 ml of 0.45 ~lithium acetoacetate and 10 mg of
Fraction V human serum albumin in 0.2 ml of deionized water. For the
blank reaction mixture 0.2 ml of deionized water was substjtuted for
the test sample.
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with the bacterial enzyme at a single sensitive site which seems to be
cationic in nature having a pK of
group (Fridovich, 1963).

5.8 or that consistent with an amino

The ionic attraction of the anions to the sen-

sitive site on the enzyme inhibits the substrate from gaining access to
the active site.

The ionic diameter of the anion seems to play an im-

portant role in the potency of the inhibitor (Fridovich, 1963).

The

series of anions listed in order of their potency as inhibitors nearly
parallels the Hofmeister series in reverse (Fridovich and Westheimer,
1962; Westheimer, 1963).
The acetoacetate decarboxylase activity of human serum albumin is
due to a sensitive lysine residue.

It is not unexpected that anions may

also inhibit the decarboxylase activity of albumin.

To further charac-

terize the acetoacetate decarboxylase activity of Fraction V human serum
albumin, the effect of monovalent anions upon the decarboxylase activity
was studied.

Four anions from the Hofmeister series were investigated:

bisulfite, thiocyanate, nitrate and chloride.

These were chosen on the

basis of their increasing effectiveness of inhibition of the bacterial
enzyme of the following order:

HSOj "> SCN->> NOj

the test reaction mixtures contained 2.6 m1 of
0.1 ml of 0.45

~lithium

50

>> cC.

For the assay,

mM Tris buffer, pH

?.4,

acetoacetate and 0.2 ml of a solution of Fraction

V human serum albumin (10 mg) and 0.1 ml of a solution of the sodium salt
of the test anion.

The control reaction mixtures were prepared similarly

except that deionized water was used instead of the test anion solution.
Various concentrations of the anion solutions were tried in setting up
the protocol.

Table 16 lists the concentration of each anion required for

a comparable degree of inhibition of acetoacetate decarboxylase activity
of Fraction V human serum albumin.
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Table 16
The Effect of Monovalent Anions on the Acetoacetate Decarboxylase
Activity of Albumin

Anion

Number of
Determinations

Concentration

Per Cent Inhibition

sen -

5

10 mM

4J.1%.:!: 2.8 (S.E.M.)

Hso;

5

10 mM

41.8%.:!:

NO-

6

80 mM

40.8%.:!: 2.6 (S.E.M.)

Cl -

6

200 mM

44.2% 2 1.0 (S.E.M.)

3

o. 7 (S.E.M.)
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The degree of inhibition caused by the monovalent anions on the
acetoacetate decarboxylase activity of human serum albumin parallels the
order of effectiveness observed for the inhibition of the bacterial acetoacetate decarboxylase.

The inhibition by monovalent anions further

characterizes the acetoacetate decarboxylase activity of albumin and gives
an indication that the sensitive site necessary for the decarboxylase
activity is cationic in nature.
The Acetoacetate Decarboxylase Activity Associated with Crystalline
Human Serum Albumin
Crystalline human serum albumin was assayed to obtain further evidence that acetoacetate
contamination.

decarbo~ilase

activity is not due to artifactual

The crystalline human serum albumin was obtained from

Calbiochem-Behring Corp., La Jolla, California.
specifications:

It had the following

catalog no. 126654; lot not. 801727; A grade; specially

prepared under non-denaturinz conditions by the method of Travis and
Pannell (1973); composition as determined by electrophoresis, 97.6%
albumin monomer, 2.4% albumin dimer, no alpha or beta globulins.
Nine 10 mg samples of the crystalline albumin were assayed in the
usual manner.

The mean acetoacetate decarboxylase activity was found to

be 0.9h ~ 0.01 (S.E.M.) units.
In practically all studies performed with Fraction V human serum
altum in the activity was in the range of 0, 90-1. 0 unit.

Thus, i t appears

that the acetoacetate decarboxylase activity of Fraction V human serum
albumin is not artifactural.

The active component is believed to be

integral to the albumin molecule.

The assay of crystalli:re albumin and

previous experiments with Fraction V albumin indicate that the acetoacetate decarboxylase activity is due solely to the presence of the albumin.

CHAPTER IV
DISCUSSION
Most biochemistry textbooks cite the decarboxylation of acetoacetate
to occur only spontaneously or nonenzymatically; a few state that the reaction is enzymatically controlled; others do not deal with the decarboxylation question at all.

In 1972, Van Stekelenburg and Koorevaar pre-

sented evidence that human serum, and more specifically, the alcumin fraction of human serum, contained acetoacetate decarboxylase activity.
'

.

Their preliminary studies indicated that human serum contained active
material whose properties were similar to those of the then known bacterial enzyme acetoacetate decarboxylase (EC 4.1.1.4 acetoacetate carboxylase ) ;from Clostridium acetobutylicum.

Among the properties of the

postulated activator in human serum were the following:

(a) the material

is not ultrafiltrable, having a molecular weight of greater than JO,OOO,
(b) the activator is albumin-like in nature, (c) the activity is not
heat-stable, (d) the activity has enzyme-like substrate depende~cy, (e)
the activity is inhibited by monoiodoacetate, urea, Hg 2 + and is activated
by lactoflavin,

Also rat liver homogenates were reported to exhibit

acetoacetate decarboxylase activity.
To follow the work of Van Stekelenburg, bovine liver homogenates
were used in an attempt to partially purify the acetoacetate decarboxylase activity,

The active component of the liver homogenates was found

to have a molecular weight less than JO,OOO as determined by ultrafiltration (Table 4) and an isoelectric point of approximatel;y 4 (Figure f.).
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Rat acetoacetate decarboxylase activity does not appear to be inducible during diabetes mellitus (Table

5).

The non-inducibility of the

catalytic activity indicates that the acetoacetate decarboxylase activity is constitutive.
Koorevaar and Van Stekelenburg (19?6) presented further evidence of
mammalian acetoacetate decarboxylase activity.

They demonstrated that

the degree of polymerization of albumin had no effect on the decarboxylase activity and that homogenates and subfractions of brain, liver and
kidney had acetoacetate decarboxylase activity.

Liver and kidney demon-

strated relatively high specific activities throughout all their subfractions, while brain exhibited an extremely high specific activity in
the nuclear fraction.
If albumin is responsible for the decarboxylation of acetoacetate
in the circulation, how does it perform this function?

The mechanism

of action for bacterial acetoacetate decarboxylase occurs through a Schiff
base intermediate which is formed between the epsilon amino group of a
sensitive lysine residue and the beta carbonyl group of acetoacetate.
To investigate whether albumin has a similar mechanism of action on
acetoacetate, albumin was acylated with dicarboxylic anhydrides.

The

acylation agents act on albumin by blocking the epsilon amino groups of
lysine on the hydrophilic surface.

Human serum albumin demonstrated

drastic reductions in the decarboxylase activity after blockage of the
epsilon amino groups.

The epsilon amino groups of lysine in the albumin

molecule play an integral part in mammalian acetoacetate decarboxylase
activity.

One noteworthy aspect of the inhibition by succinic anhydride

ts that extremely small amounts of succinate will inhibit markedly the
decarbo~rlase activity (Figure

?).

At a molar ratio of 0.25:1, succinate
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to free amino groups, the activity is inhibited by

85%. The marked in-

hibition at low molar ratios of succinic anhydride to free amino group
indicates that relatively few "active sites" are present on the
hydrophilic surface of albumin for reaction with acetoacetate.
Similar results were obtained with a second acylating agent, citraconic anhydride (Tables 7 and 8).

Low molar ratios of citraconic anhy-

dride to free amino group markedly inhibit the decarboxylase activity.
The citraconic anhydride has a distinct advantage over succinate as an
acylating agent in that it can be readily removed from its complex with
albumin by hydrolysis.

After hydrolysis, the resultant albumin samples

were found to demonstrate high levels of acetoacetate decarboxylase activities.

Thus, the acetoacetate decarboxylase activity can be inhibited

by small amounts of the acylating agent and that

68% and more of the de-

carboxylase activity can be recovered after removal of the blocking agent.
These data strengthens the findings for the blockage of the lysine
residues with succinate.
Behrens (1975) has determined the primary structure for huiTan serum
albumin.

Human serum albumin contains

58 lysine residues per molecule;

however, not all of these residues have the ability to react with acetoacetate.

The acylation of human serum albumin with dicarboxylic ar,hydrides

has shown that the acetoacetate decarboxylase activity is drastjcally inhibited by minor alterations in the free amino content.

Relatively few

lysine residues appear to play a role in the decarboxylation of acetoacetate.
A free epsilon amino group of lysine is necessary for the acetoacetate decarboxylase activity of albumin.

The necessity of a free epsilon

amino group for catalytic activity indicates that the mechanism of action
occurs through a Schiff base intermediate.

Schiff base intermediates
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are susceptible to reduction by borohydride,

In the bacterial mechanism,

borohydride will reduce the ketimine-product intermediate (Tagak:i et. al.,
1968).

The reduced ketimine-product is a stable complex which ?cts as a

~o~-competitive

inhibitor permanently tagging the enzyme with ar. inter-

mediate in the mechanism and rendering it inactive.

To investigate the

possibility of a Schiff base mechanism for the action of
toacetate, the borohydride reduction was conducted.

albumh~

0:1

ace-

Freund a:-:d ;:uenke

(19r-;2) showed that borohydride will also reduce acetone.

'i'hus, the assay

used for the determination of acetoacetate decarboxylase by head space
gas chromatographic analysis for acetone was not applicabJe.
the extent of the borohydride reduction, (Jthe substrate.

To measure

14
c) acetoacetate was used as

After reduction occurred, the albumin was tagged radio-

chemically and the formation of the reduced complex was measured by
liquid scintillation (Table 11).
The borohydride reducibility of the labeled albumin complex gives
evidence that the mechanism of action for the decarboxylation of acetaacetate by albumin occurs through a Schiff base intermediate.
Beta diketones are known competitive inhibitors of the bacterial enzyme acetoacetate decarboxylase.

The diketones react with a.

se~sitive

lysine at the active site of the enzyme and prevent acetoacetate from
gaining access to the site.

If albumin decarboxylates acetoacetate

through a Schiff base mechanism, then beta diketones would be expected to
inhibit this decarboxylation.

Acetylpyruvate (Figure 8) ar!d acetylacetone

(Figure 9), two of the simplest diketones, were shown to inhibit the
acetoacetate decarboxylase activity of albumin.

This action of the beta

diketones on the acetoacetate decarboxylase activity of albumin offers
further evidence for the operation of a Schiff base mechanism.

Acetylpyruvate, a competitive inhibitor of the bacterial enzyme,
forms a Schiff base with the active site of the enzyme rendering it inaccessible to acetoacetate,

The Schiff base which is formed between the

enzyme and acetylpyruvate is electron-rich in nature and borohydride will
not reduce electron-rich Schiff bases.

To gain further evidence for the

proposed Schiff base mechanism of action for albumin on the decarboxylation of acetoacetate, the effect of acetylpyruvate was studied on the
14
borohydride reduction of the albumin- (J- c) acetoacetate complex
(Table 12).

Acetylpyruvate was found to prevent the borohydride reduc-

tion of the labeled albumin complex.

The inhibition of the borohydride

reduction by acetylpyruvate strengthens the postulate that the
decarboxylation of acetoacetate occurs through a Schiff base mechanism.
Monovalent anions have been shown to inhibit the bacterial enzyme
by reacting with a sensitive cationic site.

The sensitive cationic site

is the epsilon amino terminal of a lysine residue in the active site of
"t.Le bacterial enzyme,

The list of anions which cause the inhHdtion

follows the Hofmeister series in reverse as studied by Fridovich (19/)J).
'1'he anions possess a critical ionic volume which is necessary to inhiblt
the bacterial enzyme.

The critical ionic volume necessary to jr.hibit

the enzyme has been explained in terms of entropy changes.

In order to

approach the cationic site, the anions must alter the hydratior: sphere of
the cationic site.

The breaking of water bonds leads to a positive or

favorable entropy change,

Once the anion has approached the cationic

site, the hydration sphere reforms,

The reformation of the hydration

sphere leads to a negative or unfavorable entropy change.

Ho·wever, the

overall change in entropy is positive and the reaction is energetically
favorable based upon the entropy change.
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It was demonstrated that monovalent anions will inhibit the acetaacetate decarboxylase activity of human serum albumin.

Four ar:ions were

used as representative of the Hofmeister series of anions studied by
Fridovich (1963): bisulfite, thiocyante, nitrate and chloride.

The con-

centration necessary to bring about a comparable degree of inhibition was
found to be as follows:
(Table 1/S).

thiocyante

= bisulfite

<

nitrate < chloride

The order of inhibition by monovalent anions on the acetoace-

tate decarboxylase activity of albumin is thus similar to that reported
for the bacterial enzyme.

The binding of these anions most likely occurs

at the sensitive lysine residues of albumin and this results

i~

a com-

petition between the anions and acetoacetate for the lysine sites.
Guanidine-HCl, a known denaturant of the secondary structure of proteins, was shown to inhibit the acetoacetate decarboxylase activity of
albumin.

Wallevik (1973) has shown by optical rotation that guanidine-

HCl will produce minor changes in the secondary structure of albumin at
concentrations less than one molar.

The acetoacetate decarboxylase acti-

vity of albumin has been shown to be sensitive to the minor secondary
....

~-

structure disruptions produced by guanidine-HCl at concentrations below
one molar (Figure 10).

The inhibition of the decarboxylase activity is

explained by the fact that albumin contains .58 lysine resldues and minor
changes in the secondary structure will make some of the lysires inaccessible to acetoacetate.

However, some of the epsilon amino groups of lysine

still remain near the surface of the albumin after denaturation unaffected and able to react with acetoacetate.

Thus, the acetoacetate decarbox-

ylase activity is not totally depleted by the denaturant.
The albumin molecule will bind one or two long chain fatty acids,
The sites for binding the fatty acids are probably hydrophobic clefts

into which the aliphatic chains are inserted,

Defatted Fraction V human

serum albumin was assayed for acetoacetate decarboxylase activity a.nd
shown to contain
serum albumin,

36% more activity than observed for Fraction V human

t 0.. 6 '=
5

13.0 (Table 14).

The long chain fatty acids of

Fraction V human serum albumin appear to sterically interfere with the
binding of acetoacetate and this results in a lower acetoacetate
decarboxylase activity.
The bacterial enzyme acetoacetate decarboxylase is very specific for
acetoacetate having no action on alpha or other beta keto acids.

Fraction

V human serum albumin is unable to decarboxylate the alpha keto acids
pyruvate and alpha ketoglutarate (Table

13). These results are not un-

expected for alpha keto acids will not form a Schiff base with primary
amines (Westheimer

1963). The inability of albumin to decarboxylate

pyruvate and alpha ketoglutarate presents evidence that the acetoacetate
decarboxylase activity associated with human serum albumin occurs via
the formation of a Schiff base intermediate.
The assay of crystalline human serum albumin demonstrates the same
acetoacetate decarboxylase activity as that observed for Fractlon V
human serum albumin.

This indicates that the activity associated with

Fraction V albumin is not due to an artificial contaminatior. of the Cohn
fractior.ation.

The assay of crystalline albumin for the decarboxylase

activity indicates the activity is integral to the albumin molecule.
Koorevaar and Van Stekelenburg

(1976) report a Km for the acetoace-

tate decarboxylase activity of albumin to be around 0.1 M.
affinity of albumin for acetoacetate is rather low.

Thus, the

The high binding

constant is compatable with the fact that during ketosis, the oxybutyrates become a primary fuel source for cardiac and

s~Pletal

muscle and,

therefore, decarboxylation of acetoacetate would not be desirable.
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Dur-

ing severe ketosis there is an increase in the proton pool and this coEtributes to the lowering of the blood pH.

The decarboxylation of aceto-

acetate removes a proton from the pool and helps combat the fallinG blood
pH.

The low affinity of albumin for acetoacetate :insures that the oxy-

butyrates will reach the target tissue.

The economy of the metabolic

pathway dictates that albumin have a low affinity for acetoacetate.
Based upon the assumption that the acetoacetate decarboxylase activity of human serum albumin occurs through a Schiff base mechanjsm, one
can rationalize some of the results reported by Van Stekelenbure ar.d
Koorevaar.

For example, Van Stekelenburg and Koorevaar (1972) reported

that human serum albumin is inhibited by iodoacetate.

Iodoc_cetate re-

acts with free sulfhydryl groups; human serum albumin contair.s only one
free half-cystine in the primary structure at position J4 (Feters, 1975).
The closest lysine residue to this half-cystine is in position 41 and
thus, it appears that the lysine-41 plays a major factor in the acetoacetate decarboxylase activity of human serum albumin.
Van Stekelenburg and Koorevaar (1972) also report a pH optimum for
the decarboxylation reaction involving albumin.

The pH optimum can be

explained in terms of the microheterogeneity of albumin (Foster et. al.,
1965); albumin undergoes an expansion and contraction with varying pH.
The microheterogeneity of albumin is present in a single donor and is
not a polymorphism within the population.

The different specieG of al-

bumin resulting from microheterogeneity can be separated by their different electrophoretic mobilities.

As the pH of albumin is lowered, a

species known as F for the fast moving electrophoretic component evolves.
In the pH range of 2-4·, ultracer:trifugal, visocit:y and diff1Jrdo1
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measurements indicate that the albumin molecule expands, becoming longer
and asymmetric without a change in molecular weight (Harrington et. al.,

1956; Foster et. al., 1965). The helical content decreases and the molecule unfolds so that the interior parts become accessible (Beuson et. al.,

1964 and Wallevik, 1973). The unfolding makes more lysine residues
available for reaction with acetoacetate.

Van Stekelenburg and Koorevaar

(1972) reported a pH optimum of 4.5. Thus, albumin is expanded and lysine residues are available to react with acetoacetate.

As the pH is

raised, another species evolves, the N or normal moving electrophoretic
species of albumin.

In the N species, the secondary structure of albumin

contracts and sensitive lysine residues become unavailable for reaction
with acetoacetate.

The microheterogeneity of human serum albumin ex-

plains the pH optimum reported by Van Stekelenburg and Koorevaar.
Van Stekelenburg and Koorevaar (1972) described an experiment in
which albumin was pretreated by heating at

so·c

for various intervals of

time before assay of acetoacetate decarboxylase activity.

The heat-

treated albumin showed a time-dependent response of inhibition.

This

thermal inactivation of albumin's acetoacetate decarboxylase activity is
due to denaturation of the molecule.

Albumin is quite resistant to ther-

mal denaturation and this accounts for the slow inactivation of the
enzymatic activity resulting from short periods of heating.

The heating

of albumin unwinds the normal secondary structure of the molecule.
After short periods of time, albumin will renature in a manner similar to
its normal structure, thereby loss of the acetoacetate decarboxylase
activity is minimized.

Longer periods of heating at 80'C will demon-

strate a higher loss of activity because more intra-chain bonds are
broken and renaturation occurs in a more random manner.

After one hour
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pretreatment of albumin at 80'C, the activity loss
activity.

is

55% of its original

Of the 58 lysine residues present in albumin, some will be-

come available for reaction with acetoacetate after renaturation and thus,
albumin still demonstrates acetoacetate decarboxylase activity after
thermal denaturation.
Van Stekelenburg and Koorevaar (1972) also report that mercuric ions
will inhibit the acetoacetate decarboxylase activity of albumin.

Hughes

et, al., (1964) have shown that mercuric ions produce dimers of albumin
by cross-linking the sulfhydryl groups.

Human serum albumin contains one

. Blockage of this group will ir.hibit the
34
lysine in position 41 in much the same way as was observed for the inhi-

free sulfhydryl group, CySH

bition by iodoacetate,
In light of the results presented in the dissertation and those
given by Van Stekelenburg and Koorevaar, it is difficult to rationalize
the relatively high specific acetoacetate decarboxylase activities
associated with rat brain homogenates.

Albumin will not cross the blood

brain barrier and it is not produced endogenously in the brain.

The

brain contains numerous compounds which could form a Schiff case with
acetoacetate in the in vitro assay, eg., dopamine, epinephrine,
norepinephrine, glutamine, serotonin and gamma amino butyric acid.

All

of these are primary amines that would catalyze the decarboxylation of
acetoacetate,

The brain also contains decarboxylase enzymes such as dopa

and amino acid decarboxylase.
acetoacetate.

It is possible that these could decompose

The pool of free amino acids in the brain extracts could

also be involved in the decarboxylation of a acetoacetate by virtue of
their free amino groups.
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Albumin is the most abundant plasma protein.

Albumin does not have

a specific function but has numerous physiological roles.

It is the

principal agent responsible for the oncotic pressure of blood, transport of fatty acids and sequestration and transport of bilirubin.

There

are other less well defined functions; albumin transports various hormones, acts as a source of amino acids and transports tryptophan.

Tryp-

tophan is the only amino acid transported by albumin (McHenamy et. al.,

1957; McMenamy and Oncley, 1958). This fact becomes very important when
discussing the acetoacetate decarboxylase activity of albumin.

Albumin

will not absorb lysine or any other amino acid besides tryptophan.

Thus,

the decarboxylation must be due to lysine residues which are part of the
primary structure of albumin.
Enzymatic activity associated with the albumin fraction is not restricted to acetoacetate decarboxylase activity.

Some of the other en-

zymatic activities associated with albumin include:

esterase (Tove,

1962, Casida and Augustinsson, 1959 and Poppet. al., 1966) and protease
(Hilson and Foster, 1971), muclease (Anai et. al., 1972) and phospholipase (Elsbach and Pettis, 1973).

Extensive purification of the albu-

min does not affect these enzymatic activities.

This indicates that the

enzymatic activities affiliated with the albumin are not artifactual
but due to albumin itself.
Albumin is a very old protein in evolutionary terms, dating back between 2-3 millions years (Peters, 1975).

It is interesting to note that

albumin is the predominant circulatory protein in all species.

However,

albumin appears to have different functional roles in the various species.
Van Stekelenburg and Koorevaar (1972) first indicated that
function as a source of acetoacetate

decarboxyla~e

activity.

albumin may
The work

103
presented in the dissertation confirms their findings, characterizes
the acetoacetate decarboxylase activity of albumin and presents evidence
that the mechanism of action for the decarboxylation of acetoacetate by
albumin occurs through a Schiff base intermediate.

CHAPI'ER V

SUMMARY AND CONCLUSIONS
Experiments performed by Van Stekelenburg and Koorevaar (Clin. Chem.
Acta

J2,

191, 1972) have demonstrated the presence of acetoacetate decar-

boxylase activity associated with human serum albumin and in rat liver
homogenates.

The purpose of this work was to investigate the acetoace-

tate decarboxylase activity of Fraction V human serum albumin, to characterize it further and to gain insight into the mechanism of
decarboxylation of acetoacetate by albumin.
Experiments utilizing bovine liver as a source of acetoacetate decarboxylase activity have shown the active material to have a molecular
weight of less than 30,000 and an isoelectric point of approximately 4.
Blockage of the epsilon amino groups of lysine in the albumin molecule with succinic anhydride has demonstrated a dose-dependent response
of inhibition on the acetoacetate decarboxylase activity.

At a molar

ratio of 0.25J1, succinate to free amino group, the acetoacetate decarboxylase activity is inhibited by

8~%.

The marked inhibition at low molar

ratios of succinic anhydride to free amino group indicates that relatively few "active sites" are present on the hydrophilic surface of albumin
for reaction with acetoacetate.
A second acylating agent, citraconic anhydride, exhibited a similar
effect on the acetoacetate decarboxylase activity of albumin.

At a molar

ratio of 0.10:1 and 0.25:1, citracon1c anhydride to free amino group, the
acetoacetate decarboxylase activity of albumin was inhibited by
104

~2%

and
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88%, respectively.

Hydrolysis and subsequent removal of the citraconyl

group resulted in recovery of the decarboxylase activity; the deacylated
albumin samples regained 92% and 68%, respective1:y, of the jritial activities.

This experiment indicates that the inhibition of acetoacetate

decarboxylase activity resulting from the acylation is reversible.
Schiff base intermediates are susceptible to reduction by sodium
borohydride,

It has been shown that concentrations of 1 mM and 2 ~
14
borohydride will reduce an albumin-(J- c) acetoacetate complex causing
between ''30% to 200% increase of label incorporated into albumin over control albumin samples not undergoing the reduction.

The reduction of the

complex by borohydride gives evidence that the mechanism of action utilized by albumin for the decarboxylation of acetoacetate occurs through
a Schiff base intermediate which forms between the carbonyl group of
acetoacetate and the epsilon amino group of lysine,
The acetoacetate decarboxylase activity associated with albumin is
inhibited by the beta diketones acetopyruvate and acetylacetone,
guanidine-HCl and various monovalent anions.

At a concentration of 80

~ acetyiacetone, the acetoacetate decarboxylase activity is inhibited

by

78~

Acetopyruvate is a more potent inhibitor; the decarboxylase

activity is inhibited on the order of '40% in the presence of only 2

~

acetopjruvate,

Acetopyruvate also will inhibit the borohydride reduc14
tion of the albumin-(;- c) acetoacetate complex indicating that the

diketone prevents the.formation of a Schiff base.

Guanidine-HCl at

concentrations below 1

~

structure of albumin.

These minor secondary structural changes in

cause minor disruptions in the secondary

albumin cause marked inhibition in the decarboxylase activity.

The

presence of 0.8 M guanidine-HCl results in a 50% loss of the acetoacetate
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decarboxylase activity of albumin.

Monovalent anions inhibit the ace-

toacetate decarboxylase activity of albumin after they are attracted to
the sensitive cationic site of the epsilon amino terminal of lysine and,
thereby, prevent the binding of acetoacetate to that site.

The concen-

tration of anion necessary to bring about a comparable degree of inhibition was found to be as follows:
chloride.

bisulfite

= thiocyanate

< nitrate<

The efficacy of inhibition by monovalent anions on the aceto-

acetate decarboxylase activity of albumin is similar to that reported for
the bacterial enzyme isolated from Clostridium acetobutylicum.
Fraction V human serum albumin will not decarboxylate the alpha keto
acids pyruvate and alpha ketoglutarate and this indicates some degree of
specificity of the acetoacetate decarboxylase activity of albumin.

The

inability of albumin to decarboxylate the two alpha keto acids is supportive evidence for the formation of a Schiff base intermediate in the
mechanism of action since primary amines will not form a Schiff base
with an alpha keto acid.
The acetoacetate decarboxylase activity of defatted Fraction V human serum albumin was 36% greater than that for Fraction V human serum
albumin.

This indicates that bound fatty acids interfere with the bind-

ing of acetoacetate to some of the catalytic sites on the hydrophilic
surface of albumin.
These data characterize the acetoacetate

decarbo~Jlase

activity of

albumin and give evidence that the mechanism of action occurs through
a Schiff base intermediate.
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